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ABSTRACT 
 
Marine derived drugs are emerging with promises to positively intervene in a range 
of diseases including viral, bacterial, fungal, and to even some forms of cancers. It is 
due to the their reduced cost and negligible side effect on patients in contrast to 
synthetic drugs available today. Hemolymph of several molluscs and arthropods are 
of particular interest for their immunomodulatory properties that enhance their 
anti-microbial and anti-cancerous mechanisms. One such potential active compound 
is hemocyanin, and hemocyanin derived proteins in the hemolymph of molluscs.  
Our research aims to uncover the immunological effects of Haliotis rubra (black 
lipped abalone) hemolymph, purified hemocyanin and hemolymph permeate. Their  
immunomodulatory properties can be key to treating Herpes Simplex Virus -1, HSV-
1, infected patients and prostate cancer patients. In this study, we cultured HaCat 
(cultured human keratinocyte) cells and Human oral primary keratinocytes (as in 
vitro model for oral administration of abalone sera) and prostate cancer cell line 
(PC-3) to observe immunomodulatory effects of the extracts on such form of cancer. 
Treatment of these cells with variable concentrations of abalone sera, purified 
hemocyanin and the sera/hemolymph permeate for optimization and determination 
of dose-dependent and time dependent immunomodulatory effects were carried out. 
It was found that a 16 hour treatment period was optimum for greatest 
immunomodulatory properties, while the permeate proved to be the most potent 
immunomodulator in the case of all three models. Six different cytokine level 
changes in the cell culture supernatant post treatment were determined using BD 
Cytometric Bead Array Kit and analyzing with Flow Cytometer. 
Results show a 50% inhibition in Interleukin-6 (IL-6) expression, 21% inhibition in 
Interleukin-8 (IL-8) expression and an increase in Tumor Necrosis Factor (TNF) 
concentration were observed after 16 hr incubation with HaCat Cells treated with 
20 % v/v sera concentration. Other cytokine levels were unaltered. On a separate 6 
day treatment of HaCat cells, results showed that the hemolymph successfully 
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primed the HaCat cell for the expression of an additional proinflammatory cytokine 
Interleukin-1β, which was not expressed previously on the 16 h treatment model. 
This shows varying immunomodulatory effects of the sera/hemolymph that rely on 
treatment frequency and length.  
There is an observed inhibition of IL-6 expression in permeate treated PC-3 cells by 
over 50%, the value followed closely by sera treatment, while purified hemocyanin 
yielded an inhibition of IL-6 expression by 27%. Additionally, the effects also extend 
to IL-8 as a 29% inhibition in IL-8 results from treatment with permeate for 5 h, 
followed by a 25% reduction from treatment with AH (purified abalone hemocyanin) 
and lastly a 16% reduction from treatment with the abalone sera.    
Further, the effect of abalone sera, AH and permeate 5 h treatment on the prostate 
cancer cell morphology was observed and results suggest that the permeate had a 
size reduction effect on the morphology on all of the cells compared to untreated 
control. 
The most significant results were obtained for primary oral keratinocytes treatment 
with the abalone sera yielding a sharp 35 fold increase in IL-8 concentration and 23 
fold increase in IL-6 concentration as compared to the untreated control. Further, 
dose-dependent effects of all extracts were subsequently confirmed on the primary 
oral keratinocytes. It has also been shown that Human Oral Keratinocytes are much 
more sensitive to the sera in terms of IL-8 modulation than IL-6 modulation.  
Hence, immunomodulatory potential of the three extracts have been studied on the 
three cell lines, and immunomodulation has been confirmed at varying degrees for 
all cases. Additionally, targeted modulation of proinflammatory cytokines IL-6 and 
IL-8 has also been observed. Particular potency in immunomodulation has been 
observed in the sera permeate component of the hemolymph.  
Further, identification of the nature of the potent hemolymph permeate was carried 
out using Western Blot technique. It was shown that the fragments of proteins 
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present in the permeate originate from the hemocyanin. According to the results, 
they are highly likely to be proteins/sub-units/clusters of functional units 
dissociated from the hemocyanin. 
These findings not only support the immunomodulatory potential of abalone sera, 
sera permeate and purified hemocyanin but also support its potential to be effective 
on the immunomodulatory treatments of HSV-1 patients and prostate cancer 
patients since literature suggests, particularly IL-6, IL-8 and TNF modulation are key 
to these diseases. 
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1.0 Introduction 
 
In this era of increasing numbers of emerging diseases: SARS (2003), 
Chikungunya (2005), swine flu (2009), MERS (2012), Ebola (2014) and Zika 
(2015), it is essential to have a stack of potential compounds and their 
mechanisms in preparation to control the deadly diseases from having a 
pandemic fate. Seoul virus outbreak struck the U.S as recently as February 2017, 
and such emerging diseases are to be expected with time. Another deadly word 
in the medical field is cancer. To date, people continue to die of several forms of 
cancer despite the exhaustive research carried out to combat the disease 
throughout the world. An estimated 130,466 new cancer cases have been 
diagnosed in Australia during 2016 (sourced from 
https://canceraustralia.gov.au). This deadly disease infests and cripples every 
organ of human body. 
 
Immunomodulation – controlling the human immune response – can be a 
potential weapon to control such diseases. In fact, immunotherapy is one of the 
most prevalent emerging fields of treatment to combat a variety of diseases such 
as ischemia reperfusion injury, acute lung injury and sepsis, Alzheimer’s disease, 
Diabetes, Parkinson’s disease, Multiple sclerosis, Myeloma, arthritis, 
autoimmune diseases, leukemia, immune deficiency syndrome, systemic 
sclerosis, and viral diseases such as Herpes simplex infections, HIV/AIDs, etc. 
  
The benefit of immunomodulation is primarily due to the concept of healing 
oneself with the fighter cells present in their own body. This organic method of 
disease treatment can be triggered by certain compounds, a great number of 
which can be derived from nature. A significant number of the synthetic 
immunomodulatory drugs available today, and on Clinical Trials, are comprised 
of molecules identical to certain naturally derived immunomodulatory 
compounds. A thorough list of these is presented in Chapter 2: Review of the 
Literature.  
 
 4 
If we differentiate between terrestrial and marine species, a significant 700,000 
different species reside in the marine world. Marine world is plagued with 
different viruses and all forms of diseases, and the fact that these species 
continue to survive and exist over millions of years give a shining hint that they 
are equipped with components of exceptionally strong immune systems. These 
immunomodulatory compounds of marine species can be used today to prolong 
human lives and better human health. This is the key factor behind increasing 
numbers of research carried out on marine-derived compounds in the medical 
field.  
 
One of the well known compounds present in the hemolymph of gastropods and 
arthropods is the blue coloured copper-based respiratory protein - hemocyanin. 
Respiration is not the only function of hemocyanin; in fact it adds greatly to the 
innate immunity of these species, as most of these species are not equipped with 
forms of immune cells.  While several hemocyanins have been identified, 
characterized and the properties researched extensively, research of 
hemocyanin from Haliotis rubra (Australian black-lipped abalone) hemolymph is 
still at dawn. The immunomodulatory properties of this hemocyanin on human 
immune system have not been studied yet.  
 
An unpublished clinical study was conducted in Marine Biotechnology 
Australia’s initiative, to test the effect of Haliotis rubra hemolymph on HSV-1 
patients: ‘A Randomised, Double-Blind, Placebo-Controlled Proof-of-Concept 
Study to Evaluate Safety and Efficacy of Topical Abalone Haemocyanin Once 
Daily for the Treatment of Herpes Labialis in Immunocompetent Patients’. This 
clinical study implemented two modes of tests, one where purified abalone 
hemocyanin (AH) was applied topically on the cold sores of patients (50mg 
applied topically once daily for 5 days within 6 hours of profromal symptom), 
and another where oral administration of 25 ml whole hemolymph was offered 
to HSV-1 patients for 10 consecutive days. There were patients with identical 
symptoms who were orally administered with placebos. Peripheral blood was 
collected from the subjects prior to the start of the study and immediately 
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following the end of the study period for natural killer cell (NK) and viral 
induced proliferation assays.  
 
All of the subjects in this study reported a substantial improvement following 
treatment with the extracts with less cold sore episodes and reduced intensity of 
cold sores. Of particular interest was the cytokine profiling before and after the 
treatment, which demonstrated a drastic modulation of interleukin-10 (IL-10) in 
all of the HSV-1 patients that were orally administered with Haliotis rubra 
hemolymph (Dr. Valtchev, 2015, pers. comm). This was the first sign of 
immunomodulation indicating a hypothesis that several other cytokines related 
to the control of HSV-1, and potentially cancer, can also be modulated on oral 
administration of abalone hemolymph.  
 
At this point, it was important to perform in vitro studies to identify the levels of 
immunomodulation, the site of immunomodulation, the optimum treatment 
time, the optimum treatment concentration, any cytotoxicity to host cells, the 
component of the hemolymph responsible for immunomodulation and to reach 
the broad view of the significance of this finding. 
 
A review of literature is presented throughout Chapter (2) of this thesis. The 
hypotheses, materials and methodology of all the experiment procedures 
conducted are outlined in detail in Chapter (3). 
Cytotoxicity analysis of abalone sera, purified AH and permeate are explained in 
Chapter (4), while Chapter (5) of this thesis incorporate the in vitro studies 
conducted with Human Primary Oral Keratinocytes and HaCat cell lines. 
Immunomodulation was determined by the quantification of proinflammatory 
cytokine concentration changes in cell supernatants pre- and post treatment 
with extracts. 
Varying concentrations of three different extracts (purified hemocyanin, whole 
sera/hemolymph and sera permeate), on several incubation time periods were 
used as treatment on in vitro cultured cells. Dose-dependent effects of the 
extracts and cytotoxicity to host cells were also evaluated. 
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The quantification of cytokine concentration changes was performed with 
the Cytometric Beads Array Human Inflammatory Cytokine Kit (BD 
Biosciences) and analysed on Flow Cytometer. The six inflammatory 
cytokines that were determined included IL-10, IL-6, IL-8, IL-1 β, IL-12 and 
TNF-alpha.  
In Chapter (6), the immunomodulatory prospect of Haliotis rubra 
hemolymph extracts were assessed on prostate cancer cell line PC-3 cells. A 
study on the effect of various extract treatment on the cell morphology is also 
outlined in this chapter.  Additionally, the origin and nature of the 
hemolymph permeate was studied using SDS-PAGE and Western Blot 
Analysis. Various concentrations of the permeate was used to rule out 
anomaly and obtain a confirmed result. 
Finally, Chapter (7) incorporates a thorough discussion of all the findings of 
this study, leading to directions for future research and a concluding remark.  
 
1.1 Objectives: 
 
 Establish and validate a suitable in vitro model for cytokine modulation 
by abalone sera. 
 Investigate the effect of abalone sera on cytokine expression in vitro. 
 Identify the specific cytokines modulated by abalone sera 
 Identify the component of the hemolymph which exert immunological 
activity 
 Determine the optimum delivery system of the drug onto patients. 
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1. 2 Hypothesis: 
(a) Proteins derived from the hemolymph of Haliotis rubra have 
immunomodulatory properties towards the human innate immune system. 
(b) The effect on immune response occurs through the modulation of certain 
proinflammatory cytokines. 
(c) Based on previous studies we hypothesize that hemocyanin is the main 
protein involved in immunomodulation in abalones.  
 
In order to assess the hypotheses, in vitro studies were designed to treat 
keratinocytes (HaCat cells and Human Oral Primary Keratinocytes) and cancer 
cells (PC-3 prostate cancer cell line) with variable concentrations of Haliotis 
rubra hemolymph and the consequent modulation of expressed 
proinflammatory cytokine levels in the cell supernatant was assessed using flow 
cytometry.  
 
In order to identify the component of the hemolymph that is responsible for the 
immunomodulatory behavior, hemocyanin was purified from the hemolymph. 
Purified hemocyanin (retentate) and the permeate, along with unprocessed 
hemolymph was then used as treatment extracts. This was also done to 
determine the most potent immunomodulator, and ascertain if all the three 
extracts were effective in immunomodulation of the cells.  
 
Dose dependent immunomodulatory effects of the extracts were then assessed, 
with variable concentrations of the treatment extracts on the cells. Time-
dependent immunomodulatory effects of the extracts were also assessed, that 
involved a variation of treatment duration and the corresponding modulation of 
proinflammatory cytokines. 
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1.3 Significance 
Targeting the immune system to alleviate diseases is a crucial aspect in 
medicine because most chronic diseases have an immune component. The 
critical role of the immune system with respect to HSV-1 recurrence has 
been well studied and demonstrated (citation needed) but this promising 
therapeutic route has not been exploited. There are no drugs on the 
market which target this interaction. Current anti-viral drugs available 
against HSV-1, such as acyclovir, are not effective in immune-
compromised patients. Moreover, these drugs do not have any effect on 
the recurrence of the disease, which is a major issue in HSV infected 
patients. Investigating the immunomodulatory potential of abalone sera 
and its components, identifying which component from the abalone sera 
is the active ingredient, what it does and what is the mechanism of action, 
can have implications beyond the treatment of HSV and may help treat 
other viral infections and forms of cancer. Since the number of 
immunomodulatory drugs available is limited, new immunomodulatory 
candidates are needed. There are added benefits of this candidate 
originating from a naturally occurring marine derived extract. 
 
The novel aspects of this research include: 
 Immunomodulatory properties of whole abalone hemolymph and 
hemolymph permeate on human primary oral keratinocytes have 
not been studied previously. 
 Immunomodulatory properties of Haliotis rubra abalone 
hemocyanin (and other hemolymph components) have not been 
reported previously. 
 The origin of the abalone hemolymph permeate proteins is a 
novel finding.  
 The effect of Haliotis rubra hemolymph on the morphology of 
Prostate cancer cells has not been observed previously. 
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 Anti-cancer effects and immunomodulation of prostate cancer 
cells with treatment of Haliotis rubra whole hemolymph has not 
been investigated previously. 
 The component of abalone hemolymph that induces the greatest 
immunomodulation among other abalone hemolymph 
components has not been identified before.  
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CHAPTER 2: 
 
Review of the  
Literature 
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2.0 Introduction 
 
Marine derived drugs are emerging at a rate higher than ever as research is 
being carried out on selective species constituents from the pool of a staggering 
700,000 different marine species. This promising variety and their successful 
existence over millions of years despite inhabitancy with harmful viruses and 
bacteria in the marine world, is indeed a strong indication that marine derived 
drugs can help human health.  
 
Abalone hemocyanin is such a marine derived extract that have shown to be 
active in multiple instances, and in particular helps patients with HSV-1 when 
orally consumed before and during outbreaks. A report, with substantial 
evidence from the blood of patients who dose dependently ingested abalone sera 
for ten days, showed that the level of cytokines, in particular IL-10, were 
reduced. This indicates an immune response triggered by hemocyanin that helps 
alleviate and reduce the frequency of HSV-1 outbreaks. The hypothesis that 
immune system modulating effect due to abalone sera takes place in contact with 
epithelial and neighbouring cells in the mouth and gut prior to digestion is to be 
tested in this project, while the aim remains to map out the immune response 
pathway and ultimately devising an abalone hemocyanin derived anti-viral drug. 
 
While reviewing the literature for the titled research project, it was important to 
look closely at the existing findings and on going research in the field of 
immunology and marine derived drugs. In particular, there is emphasis placed 
on the mechanisms and importance of innate immunity, branching out to 
cytokines. Both marine derived drugs available commercially and those 
undergoing clinical trials are discussed. Other immune system modulating drugs 
and their mechanism are evaluated. However, the first point of discussion is the 
suspected active ingredient within the abalone sera, hemocyanin itself. The 
structure, properties and functions of both molluscan and arthropod 
hemocyanin are thoroughly researched and put together that advocates the 
potency of this multifarious molecule based on findings so far. 
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2.1 Hemocyanin 
 
            2.1.1 Structure of hemocyanin from arthropods and molluscs  
 
The transport of oxygen is an essential feature for aerobic metabolism, 
thus life, in most animals. The widely known haemoglobin has two other 
lesser counterparts hemerythrins and hemocyanins (Kensal et. al, 2001). 
In 1878, Léon Fredericq, discovered and named hemocyanin, which are 
respiratory glycoproteins present in the hemolymph of arthropods and 
molluscs (Holde et. al, 1992); oxygen binding, transport and release is the 
primary function of the protein.  In the molluscan hemocyanins, each 
functional unit (FU) within the protein subunit contains two copper 
binding sites that can bind to one molecule of oxygen (O2). As the copper 
is in cuprous state, oxygen binding generates a particular light 
absorbance at 340 nm, causing the blue colour of oxygenated 
hemocyanins (Harris et. al, 1999). 
 
There are some inherent difference in the structure of hemocyanin from 
arthropods and molluscs. Arthropod hemocyanins consist of multiple 
hexamers, each of which is made up of monomers weighing 
approximately 75 kDa (Durstewitz et. al, 1997; Feldmaier et. al, 2000). 
Variations of the common monomer sequence occupy a certain position 
on the whole molecule. The hemocyanin subunit is divided into three 
domains, and the highly helical domain contains the active site copper 
pair. Each of the copper is ligated with three histidine residues (Volbeda 
et. al, 1989).  
 
Molluscan hemocyanins on the other hand, have structures built from 
large polypeptide chains of 350-450 kDa, each divided into 7 or 8 
functional units weaved through linker peptide chains (Lieb et. al, 2000). 
Within the various molluscan hemolymph, hemocyanin molecules may 
exist as subunits of dimers, decamers, or oligomers of the decamers, 
 13 
causing hollow cylindrical arrays of very large sizes resulting in as many 
as 160 active sites per molecule (Hazes et. al, 1993). The two domains of 
such hemocyanins are of N terminus (highly helical) and C terminus (β-
sheet). The two copper sites are positioned such that they are well 
separated; one near the N-terminus and the other near the C- terminus. 
Each copper site is ligated by histidine residues, similar to the arthropod 
hemocyanin (Magnus et. al, 1994).  
 
            2.1.2 Properties and functions of hemocyanin  
 
Hemocyanin typically encompasses up to 95% of the total protein in the 
hemolymph of molluscs and arthropods, and has proven to be involved in 
a varied range of functions in addition to the respiratory objective. These 
include osmoregulation, energy storage, molt cycle, exoskeleton 
formation and immune defense (Zheng et. al, 2016; Coates et. al, 2014; 
Decker et. al, 2007). 
 
Hemocyanin from various species has been widely studied for its anti-
viral, anti-bacterial, anti-fungal, anti-cancer and immunogenic activities 
over the past three decades. The substantial findings have placed 
hemocyanin as a key interest to researchers in the field, and its potency is 
still unraveling in the recent years. 
 
            2.1.3 Immune system modulating potential of hemocyanin 
 
The immunomodulatory effects of hemocyanin, particularly keyhole 
limpet hemocyanin (KLH), have been established in a number of different 
studies both in vivo and in vitro. Murai et. al (2015) found a direct 
relation between the reduction of IL-10 gene expression in orally 
immunized chicken with KLH in response to anti-biotics. IL-10, which is 
mainly produced by T-regulatory cells (Treg), suppresses immune 
responses and contributes to immune tolerance in the intestine 
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(Veenbergen et. al, 2012). This is a promising result since recent study by 
Shanmugasundaram et. al. found the close similarity between the 
regulatory immune system of chickens to that of mammalian Treg cells, 
deducing that CD4+ CD25+ cells in chickens are analogous to mammalian 
Treg cells that produce considerable amounts of IL-10 and TGF- β 
(Shanmugasundatam et. al, 2011). Similar reduction in IL-10, along with 
IL-4 and IL-5 was observed by Kamachia et. al in BALB/c mice when they 
were injected with antigen KLH induced OX40L cDCs (conventional 
dendritic cells). This indicated a reduction in Th2 production in the lymph 
node of these mice (Kamachia et. al, 2014). In a study of the effect of 
Strontium 90 ingestion in mice that were previously vaccinated with 
antigens of KLH and TT (tetanus toxin), there was no reduction in the IgG 
specific to KLH (a strong Th2 inducer antigen). In contrast there was an 
increase in immunoglobulins specific for the KLH antigen (Nicholas et. al, 
2016). Effect of hemocyanin on the level of cytokine and antibody 
production provides a degree of clarity to its immunomodulatory 
potential. 
 
2.1.4 Anti-fungal, anti-viral and anti-cancer properties of 
hemocyanin, and use of hemocyanin as a conjugate vaccine 
…………………………………. 
In vitro studies on fungal spores demonstrated an interesting finding 
where a particular mechanism was adopted by Penaed shrimp 
hemocyanin to combat fungal cells. This mechanism involved the peptide 
PvHCT, released from the C-terminus of hemocyanin, adopting an alpha 
helical structure in membrane-mimicking media and displaying a random 
conformation in aqueous environment. In contact with F. oxysporum, 
PvHCt bound to the surface of fungal hyphae but there was no import into 
the cytoplasm. Notably there was a gradual degeneration of the cytoplasm 
resulting in cell lysis in fungal spores and hyphae (Petita et. al, 2016). This 
is further supported by Destoumieux-Garzón et. al. in the study of infected 
penaed shrimp plasma, which appeared to contain an elevated amount of 
peptides derived from the C-terminus of its hemocyanin, revealing that 
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microbial infections trigger the increase of these peptides in shrimp 
plasma (Garzon et. al, 2001).  
 
Hemocyanin acts as an anti-viral agent in the hemolymph of Red Swamp 
Crayfish when the fish is exposed to White Spot Syndrome Virus (WSSV). 
Two hemocyanin subunit genes of Crayfish challenged with WSSV showed 
the same regulation pattern in terms of their mRNA levels, which 
indicated that both of these genes may participate in the anti-viral 
immune response of crayfish (Zeng et. al, 2008). This is an example of 
how hemocyanin is responsible in immune modulation in species that 
carries it. In other words, it serves as an immune defense component in 
the crayfish (and abalone). This has been extended to study the anti-viral 
effect of hemocyanin on mammalian viral infections, including the very 
common Herpes Simplex Type 1 Virus (HSV-1). Vero cells infected with 
HSV 1 were treated with abalone hemocyanin on a dose dependent 
manner where inhibitory effects through a receptor mimicking 
mechanism were observed.  Viral attachment and entry to Vero cells was 
inhibited through specific binding with the viral surface glycoproteins, 
and this was also achieved by using a small dimer subunit of the 
hemocyanin indicating that only a small hemocyanin analogue could be 
used for its antiviral activities (Zanjani et. al, 2016). Peptides based on the 
overlapping fragments of the haliotisin region of abalone hemocyanin 
(located within the linking sequence between the α-helical domain and β-
sheet domain of abalone hemocyanin functional unit E), which is 
considered as the putative anti-microbial region, were tested for their 
bactericidal potential through incubating Gram-positive and Gram-
negative bacteria in the presence of certain haliotisin peptides. There was 
significant reduction in microbial growth and additional damages to the 
microbial cell wall (Zhuang et al, 2014). A novel approach that is 
increasingly being adopted and tested by researchers is the use of 
hemocyanin as a bio-ajduvant. The adjuvants are substances that have the 
ability to enhance the magnitude and duration of the immune response 
and to increase vaccine efficacy. Gesheva et. al. tested hemocyanin from 
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gastropod Helix pomatia as a bio-adjuvant for bacterial antigens, where 
hemocyanin was combined with tetanus toxoid and the complex was used 
for immunization on mice. This resulted in an increased number of anti-
TTIgG producing plasmocytes and induced a significant increase of B and 
T cell proliferation (Gesheva et. al, 2006). Bio-adjuvant hemocyanin which 
acts as a natural protein carrier for vaccine, further illustrates its ability 
to orchestrate the immune response in an effective manner for bacterial 
attacks. Immunogenicity of similar conjugates were tested with 
Trinitrophyl-KLH on rabbits, that induced an average of 375 µg of anti-
TNP antibody and up to 2.5 mg of anti-KLH antibody per ml serum within 
a week after second injection (Marvin et. al, 1966) This further validates 
the potency of KLH as an adjuvant in inducing immune response.  
 
The use of hemocyanin as an adjuvant is being implemented for 
treatments of various types of cancers due to its cancer cell specific 
inhibitory effects. Rapana thomasiana hemocyanin adjuvants with choline 
amino acid salts has specific anti-proliferative effects on breast cancer 
cells in vitro, and in contrast stimulatory effects on fibroblasts (Guncheva 
et. al, 2015). An in vivo study of KLH conjugate vaccines for melanoma 
showed that mice immunized with these conjugates had a stronger 
antibody response to G(D3) than mice immunized with unconjugated 
G(D3). The strongest response was observed in mice immunized with the 
KLH conjugate of the G(D3) aldehyde derivative and the adjuvant QS-21. 
These mice showed a long-lasting high-titer IgM and IgG response 
indicating recruitment of T-cell help (Helling et. al, 1994). Later the same 
year, this study went to the clinical trials phase – I to be tested as vaccine 
on patients with malignant melanoma identifying 100 mu g dose of QS-21 
as the optimal well tolerated dose for induction of antibodies against both 
the melanoma ganglioside/GM2 and the protein KLH in melanoma 
patients (Livingston et. al, 1994). The rapid advancement accredits itself 
to the promise of hemocyanin as a potential anti-cancer drug.  
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Bladder cancer cells responded to Helix lucorum and Rapana venosa 
hemocyanin in vitro by showing anti-tumor activity of both the 
hemocyanins through induction of apoptosis. Besides the antiproliferative 
effect, there was downregulation of the genes with metastatic potential 
(Antenova et. al, 2015). Hemocyanin from shrimp showed similar 
antiproliferative effect on cervical cancer cells, Hela Cells, through 
apoptosis in HeLa cells characterized by the formation of apoptotic body-
like vesicles, chromatin condensation and margination. In addition, the 
reactive oxygen species (ROS) and caspase-9/3 activities significantly 
altered in hemocyanin-treated HeLa cells (Zheng et. al, 2016). 
 
The potential of hemocyanin further extends to its application in 
contraception. GnRH-hemocyanin conjugate immunocontraceptive 
vaccine formulation was used and it successfully prevented reproduction 
and inhibited production of sex hormones in various mammalian species, 
particularly feline species, for an extended period of time (Sung et. al, 
2015). 
 
2.2 Innate immunity 
 
Specific bacteria with the doubling time of one hour can reproduce into as many 
as 20 million a day to infect the host (Alberts et. al, 2002). At this rate, immediate 
immune response to combat the infection is vital. Innate immunity takes action 
within hours of the bacterial infection, while otherwise relying on the adaptive 
immune response would takes effect in as much as few days that could 
potentially cost a life. Hence, the importance of innate immunity is evident.  
 
Innate immunity is a primordial immune defense system, which every individual 
is gifted from birth. (Wiley et. al, 2009) As first line of defense, a number of 
physical and chemical barriers are present to prevent further entry of foreign 
bodies. Majority of foreign bodies cannot penetrate skin, while some may enter 
through sebaceous glands they are immediately fought with fatty acids and 
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hydrolytic enzymes. Skin also has an additional supply of lymphocytes and 
plasma cells beneath the epithelium. (Edwin et. al, 1982) Innate immunity 
mechanism also includes mucus in respiratory and gastrointestinal tracts which 
entraps most microorganisms and the cilia lining in epithelial cells facilitates 
their quick exit. Macrophages in the alveoli deal with any substances that remain 
in the respiratory tract by phagocytosis. Neutrophils are the most abundant 
leukocyte in humans and essential to the innate immune response against 
invading pathogens. The ability of neutrophils to kill microorganisms is 
immediate, non-specific, and not dependent on previous exposure to 
microorganisms. Microglial cells in the central nervous system phagocytose 
those who find their way to that area while acidity of the stomach, bile in small 
intestine and enymes in saliva contribute further to innate immunity. (Wiley et. 
al, 2009) The thymus, spleen, tonsils, lymph nodes, appendix and bone marrow 
are the major organs participating in our immune system, from being the 
originators of cells of immunity to the mediators of our immune system (Edwin 
et. al, 1982). 
 
2.2.1 Use of PAMPs, PRRs and TLRs 
 
The fundamental mechanism by which innate immunity functions is by 
distinguishing self from non-self. This prevents the immune response 
from destructing own cells, absence of which would prove to be fatal. 
Infectious agents possess invariant molecular constituents that are 
essential for the microbe’s survival. Hence, these special components are 
not subject to mutations or variability, moreover these structures are 
common across infectious microorganisms. Innate immunity has evolved 
over the years to combat this common series of Pathogen-Assiociated-
Molecular-Patterns (PAMPs) present in every invading pathogens. 
Lipopolysaccharides, techoic acids and double stranded RNAs are some 
examples of PAMPs (Ruslan et. al, 1987).  
The media used by host cells to recognize these structures are germline-
encoded Pattern Recognition Receptors (PRRs) which may be present 
extracellularly, intracellularly or secreted by host defense cells.  
 19 
One such example is the transmembrane protein Toll like receptors 
(TLRs). TLRs have a cytosolic region identical to IL-1 receptors and thus 
this domain is termed TIR. The ectodomain contains leucine-rich repeats. 
Each of these domains serve a purpose with the extracellular domain 
focusing on the recognition of PAMPs, while the TIR domain mediating 
signal transduction (Taro et. al, 2010) Eleven different proteins have been 
identified in mammalian TLRs, and each are fine-tuned to recognize 
specific PAMPs and induce varied necessary signaling pathways. NFkB 
(Nuclear Factor Kappa Beta), MAPK (Mitogen Activated Protein Kinase) 
and IRF5 (Interferon Regulatory Factor 5) are common signaling 
pathways amongst many induced by different TLRs, resulting in the gene 
encoding and transcription of immunomodulation messenger proteins 
such as cytokines, TNFs  and interferons (Taro et. al, 2005).   
 
TLRs recognize and respond to infectious agents both on the extracellular 
and intracellular region of cells. Intracellular microorganisms are also 
recognized by nucleotide binding oligomerization proteins (NOD 1 and 
NOD 2), that may induce the according signal transduction (Takeda et. al, 
2005).  
 
2.2.2 Other aspects of innate immunity 
 
Opsonization (binding the pathogen for aided engulfing) and 
phagocytosis (ingestion and elimination of pathogens) are the other arms 
of innate immune response, which are highly well integrated with 
selective “division of labor” between cells and targets for effective 
elimination of the foreign invader. Phagocytic immune cells such as 
macrophages have ancillary receptors to identify specific types of 
microorganisms to orchestrate the optimum means of phagocytosis 
(Spencer et. al, 2014).  
 
A crucial finding in immunology relates to innate immunity’s direct 
influence on the functions of adaptive immunity, which was formerly 
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considered as mutually exclusive. Innate immune response not only 
initiates but also subsequently orchestrates the pathway taken by 
adaptive immunity. Additionally, innate immunity takes considerable 
responsibility in dealing with the infectious agents already targeted by 
adaptive immune response (Janeway et. al, 2001; Akiko et. al, 2015). 
2.3 Cytokines of the innate immune system 
During an immune response, small protein molecules ranging from 8 - 40,000 
Daltons (Watkins et. al, 2013) are secreted by immune cells (e.g T helper cells or 
macrophages) or non-immune cells (e.g endothelial cells or fibroblasts), which 
help cell to cell communication and interaction (Jun-Ming et al, 2007). Cytokine 
is the generalized name of a collection of such molecules including lymphokine 
(cytokines made by lymphocytes), monokine (cytokines made by monocytes), 
chemokine (cytokines with chemotactic activities), and interleukin (cytokines 
made by one leukocyte and acting on other leukocytes) (Richard et. al, 1997) . 
Secreted cytokines may act in three different manners: autocrine where the 
cytokines act on the cells that they have been secreted from, paracrine where 
they act on nearby cells, and endocrine where they act on cells positioned at a 
distance (Constantin et. al, 2007). In an immune response, cytokines may either 
have pro-inflammatory effects or anti-inflammatory effects, and all cytokines are 
attributed to each specific category of effects (Angus et. al, 1997).  
Different cell types secrete the same cytokine while a single cytokine can act on 
several different cell types (i.e pleiotropy). Additionally, similar immune 
response can be stimulated by different cytokines. Generally, cytokines are 
produced in a cascade where one cytokine stimulates the target cells to produce 
additional cytokines (Robin et. al, 1996).  
2.3.1 Proinflammatory and anti-inflammatory cytokines 
 
Proinflammatory cytokines have been extensively studied in conditions 
such as periodontal disease (Sledziewski et. al, 2015), coronary heart 
disease (Provotorov et. al, 2015), non-alcoholic fatty liver disease 
(Stojsavljevic et. al, 2014), colon cancer (Hummel et. al, 2014) and so on. 
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Interestingly, increased levels of proinflammatory cytokines like TNF-
alpha and IL-6 are associated with aging (Brunsgaard et. al, 2001).  
Increased proinflammatory cytokines IL-1 and TNF-alpha is responsible 
for the defect in Erythropoietin production in severe systemic and renal 
inflammatory diseases (Jelkmann et. al, 1998). Hence, reduction in the 
biological activities of proinflammatory cytokines is necessary to prevent 
harm to host and promote healing. Biological activity of IL-1 and TNF can 
be achieved by several different strategies, including neutralizing 
antibodies, inhibitors of proteases receptor antagonist, and soluble 
receptors (Dinarello et. al, 2000). 
 
Anti-inflammatory cytokines on the other hand control the 
proinflammatory cytokine response. This concert of cytokines with 
specific cytokine inhibitors and soluble cytokine receptors regulate the 
human immune response. Some of the major anti-inflammatory cytokines 
are IL-10 and IL-13 (Opal et. al, 2000).  
 
            2.3.2 Interleukin-6, Interleukin-8 and Interleukin-10 
 
Interleukin-6, IL-6, was initially recognized for its ability to promote the 
population expansion and activation of T cells, the differentiation of B 
cells, and regulation of the acute-phase response (Yasukawa, K. et al. 
1987; Hirano, T. et al. 1986). Hormone-like attributes of IL-6 affecting 
vascular disease, insulin resistance, the neuroendocrine system and 
neuropsychological behavior was later recognized (Bethin et. al 2000; 
Kraakman et al. 2015). The structure of IL-6 is illustrated in Fig. 2.0. 
Majority of stromal cells and cells of the immune system secrete IL-6. It is 
produced mainly by certain pathways involving Toll-like receptors, 
prostaglandins, adipokines, stress responses and other cytokines. IL-1β 
and tumor-necrosis factor are major activators of IL-6 expression as well. 
Concentrations of IL-6 in normal human serum are as low as 1–5 pg/ml, 
but these are rapidly increased in disease conditions (Wagee et. al, 1989). 
IL-6 is, in fact, a better predictor of disease activity as infection, 
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autoimmunity and cancer have an associated elevated IL-6 (Fraunberger, 
P. et al. 2006; Mroczko et. al 2010;  Panichi et. al, 2004).  
 
On the other hand, as IL-6 is a lymphocyte-stimulating factor, its 
deficiency causes impaired innate and adaptive immunity to viral, 
parasitic and bacterial infection (Dienz, et. al 2012; Garbers, et. al 2011; 
Hoge, et. al 2013; Smith et. al, 2014). 
                                  
Figure. 2.0: Structure of Interleukin- 6. Source: Xu et. al (1997) 
 
IL-6 modulates almost every aspect of the innate immune system, such as 
hematopoiesis and the migration of neutrophils at sites of infection 
through the control of granulopoiesis (Chou et. al 2012; Liu et. al 1997). 
The driving force behind this is the regulation of neutrophil-activating 
chemokines and neutrophil apoptosis by IL-6. IL-6 reduces influenza 
virus–induced inflammation and protects against fatal lung pathology 
(Launder et. al, 2013). Competent host defense, excessive tissue damage 
prevention and the transition from the recruitment of neutrophils to the 
recruitment of mononuclear cells are further effects controlled by IL-6 
(Lally et. al, 2005). IL-6 augments macrophage differentiation and 
restricts the formation of dendritic cells in vitro (Chomarat et. al, 2000), 
and controls the macrophage colony-stimulating factor receptor (encoded 
by Csf1r) (Jenkins et. al 2004). IL-6 also inhibits activation of the 
transcription factor NF-κB.  
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In the adaptive immune system, IL-6 is identified as a lymphokine that 
triggers the maturation of B cells into antibody-secreting cells. It is also 
involved in the survival and maintenance of long-lived plasma cells. This 
was supported by reports that Il6−/− mice immunized with a T cell–
dependent antigen showed lower immunoglobulin G production than 
wild-type mice. It was also demonstrated that IL-6 deficiency correlates 
with diminished antibody responses and susceptibility to infection (Kopf 
et. al, 1994). Castleman’s disease is one such clinical example of IL-6 and 
B cell association. Furthermore, the ability of IL-6 to promote humoral 
immunity is due to its effects on follicular helper T cells (TFH cells), a 
specialized subset of CD4+ T cells that express the chemokine receptor 
CXCR5 and localize to B cell follicles. It is there that they promote B cell 
proliferation and immunoglobulin class switching (Ma et. al, 2012). IL-6 
serves as a central link between T cell responses and B cell responses 
(Nurieva et. al, 2008; Dienz et. al, 2009; Harker et. al, 2011).  
 
Interleukin-8 (IL-8) belongs to a family of small, structurally related 
cytokines similar to platelet factor 4. IL-8 is a chemotactic factor that 
attracts neutrophils, basophils, and T-cells, but not monocytes. It is also 
involved in neutrophil activation. It is released from several cell types, 
including macrophages, epithelial cells, endothelial cells and other cell 
types (Hedges et. al, 2000), in response to an inflammatory stimulus. The 
structure of IL-8 is illustrated in Fig. 2.1. The primary function is not only 
inducing chemotaxis of neutrophils and other granulocytes in target cells, 
and causing them to migrate toward the site of infection but also inducing 
phagocytosis once they have migrated to the site. IL-8 increases Ca2+ , 
exocytosis and the respiratory burst (Modi et. al, 1990).  
 
Interleukin-8 secretion is increased by oxidant stress, cyclically causing 
the recruitment of inflammatory cells and inducing an increase in oxidant 
stress mediators itself, making it a key parameter in localized 
inflammation (Vlahopoulos et. al, 1999).  
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IL-8 has demonstrated significance in a number of clinical situations; it 
has been cited as a pro-inflammatory mediator in gingivitis (Haake et. al, 
2002) and psoriasis, autocrine growth factor for colon carcinoma cell 
lines (Brew et. al, 2000), elevated IL-8 has been linked to schizophrenia 
(Zhang et. al, 2004), and IL-8 has also been implicated in the pathology of 
cystic fibrosis (Reeves et. al, 2011). 
                             
Figure 2.1: Three-dimensional structure of interleukin 8 in solution. 
Source: Clore et. al, (1990) 
 IL-10 is particularly of interest since it is produced by a variety of 
immune and non immune cells, and its level in blood or cell supernatant 
from various treatment of infections can be a key indicator of the 
immunological effects of the treatments. It primarily inhibits the action of 
Th1 cells, NK cells and macrophages during infection. This helps prevent 
tissue damage. As a consequence IL-10 impedes pathogen clearance and 
ameliorates immunopathology. IL-10 is mainly produced in different 
tissues during acute or chronic infections (Coupar et. al, 2008). In 
addition to the anti inflammatory action of IL-10 however, there is a 
paradoxical degree of pro-inflammatory effect demonstrated by IL-10 as 
many reports suggest that IL-10 enhances the function of NK cells, 
causing an increased antigen availability. Also, IL-10 preserves the ability 
of antigen presenting cells for antigen uptake. This also hampers their 
migration to draining lymph nodes (Mocellin et. al, 2003). 
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2.4 Marine derived immune response modulating compounds 
 
A number of marine derived compounds have shown to regulate 
cytokines in vivo and in vitro in the recent years. Orally administered 
Oligosaccharides of kappa/beta-carrageenan from the red alga 
Tichocarpus crinitus, induced IL-10 production in human blood cells. 
Compared to the source polysachcharide, the low molecular weight 
counterpart induced more IL-10. Polysachcharides from lichens have 
shown to have immunostimulatory effect in some studies as well 
(Sreshtha et. al, 2015; Hirabayashi et. al, 1989; Schepetkin et. al, 2006). A 
comprehensive list of marine derived immunomodulatory compounds is 
outlined in Table 2.2.  
 
Other compounds such as seaweed lectins, or Pseudopterane Diterpene 
isolated from the octocoral pseudopterogorgia acerosa, particularly the 
latter have shown to have anti-inflammatory effects through the 
inhibition of inflammatory mediators. It also inhibited the macrophage 
activation and initiation of adaptive immune response (Gonzalez et. al, 
2013; Rivanor et. al, 2014). Marine sponge-derived reagent alpha-
galactosylceramide (alpha-GalCer), induces a rapid production of 
cytokines and activation of other immune cell types (Parekh et. al, 2013). 
11-episinulariolide acetate from soft coral reduced COX-2 and IL-8, and 
blocked intracellular Ca2+ increase and Ca2+ dependent transcription 
factor activation in human epidermoid carcinoma cells, which can be used 
for targeting Ca2+ signaling-dependent inflammatory diseases (Hsu et. al, 
2013). 
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            2.4.1  Immune system modulating marine drugs 
 
A number of marine derived drugs are on shelves today, continuing to 
alleviate human diseases. Acyclovir, a derivative of Ara-A from marine 
sponge Cryptotethya Cryta, is the primary drug for Herpes Simplex Virus 
type 1 and 2 (HSV).   
 
Acyclovir, an acrylic purine nucleoside analog, which although is an 
inhibitor of HSV, has very low toxicity for the normal host cells. The 
reason for this selectivity is that these viruses code for a viral thymidine 
kinase that phosphorylates acyclovir to a monophosphate; uninfected 
cells are incapable of this (Elion et. al, 1982). Cellular enzymes later 
convert this acyclovir monophosphate (acyclo-GMP) to acyclovir 
triphosphate (acyclo-GTP). Acyclo-GTP persists in HSV-infected cells for 
many hours after acyclovir is removed from the medium. Acyclo-GTP acts 
as a more potent inhibitor of the viral DNA polymerases than of the 
cellular polymerases (Brigden et. al, 1983). Pachnio et. al. found the 
immune response modulating potential of Acyclovir showing that low 
dose acyclovir treatment has the potential to modulate components of the 
T cell response to Cytomegalovirus (CMV) antigen proteins (Pachnio et. al, 
2015). 
 
A well known immune modulatory drug is Cyclosporine, a cyclic 
undecapeptide from the marine fungus Microdochium nivale, which has 
immunosuppressive effects because they block T-cell activation or 
proliferation (Stuart et. al, 1992). Activation is the G0-GI cell-cycle 
transition , which takes place due to the antigen binding to the T-cell 
receptor (TCR). Genes such as those encoding the interleukin-2 (IL-2) and 
its receptors are switched on by the consequent Ca2+ dependent TCR 
signal transduction pathway. On the other hand, proliferation occurs at 
G1-S transition that recruits from autocrine signaling by ILh-2 (Jeannette 
et. al, 1993). Cyclosporine was initially used as an immunosuppressant 
drug to prevent rejection in organ transplant patients, but have now 
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being applied to diseases such as rheumatoid arthritis and severe 
psoriasis (Lowe et. al, 1996).   
 
Various marine derived drugs have entered Clinical trials including IPL-
576 (aka HMR-4011A) from marine sponge Petrosia contignata, which 
inhibits the release of histamine from mast cells and lung tissue enabling 
itself to be a treatment as an anti-allergen for asthma. It has passed 
Clinical Trial phase II in 2002 (Singh et. al, 2008). KRN7000, a glycolipid 
that has a novel α-galactosylceramide (α-GalCer) structure, is no longer 
extracted from the native source marine sponge, but is chemically 
synthesized, which exhibits potent anti-tumor activity through 
stimulation of a strong immune response in Natural Killer Cells (NKT 
cells).  (Alline et. al, 2011; Chang et. al, 2005).   
 
The most common mechanism of action of marine derived drugs to date 
is, however, through inhibition of tumor cell proliferation in association 
with G(2)-M arrest and tubulin polymerization and microtubule 
stabilization (Iwasaki et. al, 2015). 
 
Besides drugs, application of commercially available marine bioproducts 
extends to molecular probes, such as manoalide and green fluorescent 
protein (GFP), enzymes such as vent and deep vent DNA polymerase, 
nutritional supplements such as formulaid from marine algae, and 
pigments like phycoerythrin (Roger et. al, 2002). 
 
2. 5  Viruses and the Human herpes simplex virus (HSV) 
 
Virology, the study of viruses, originated during the 1890s when infectious 
agents targeted tobacco plants. However, the evidence of viral infections dates 
back to 1157 BC with the discovery of small pox lesions present in the 
mummified body of the young pharaoh Ramses V. The viral pestilence timeline 
incorporates the prevalence of small pox throughout the early 15th century, 
followed by outbreak of measles, dengue fever, influenza and polio until early 
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18th century. AIDs epidemic spread through early 1980s and the culprit was 
finally discovered as the human immunodeficiency virus (HIV) by Luc 
Montagnier. During the past two centuries, there have been considerable 
accounts of new viral outbreaks including Zika (first isolated from humans in 
Nigeria in 1954), Asian influenza, Rubella, Marburg hemorrhagic fever originated 
from infected African green monkeys from Uganda, Germany and Yugoslavia. 
Ebola, SARS, Avian influenza Chikungunya, Porcine reproductive and respiratory 
syndrome, Schmallenberg, Swine Flu, Hantavirus, MERs, Zika and Powassan 
virus have been most prevalent and damaging in the last two decades 
(Woolhouse et. al, 2012). HSV type 1 and type 2 viruses are very common to 
date, with the former, affecting 80% of the Australian population.  
With emerging viral diseases there has been numerous advents of virus 
discovery techniques. To briefly outline in chronological order of virus discovery 
technique implementation Filtration technique is the most classical method 
developed in 1890s, followed by Complement fixation technique (1929), Mice, 
embryonated eggs and electron microscopy in 1930s,Tissue culture as host in 
late 1940s, Monoclonal antibodies and Sanger Sequencing in 1970s, Polymerase 
chain reaction (PCR) in mid 1980s, Bioinformatics in 1990s followed by most 
recent techniques of high throughput sequencing, Panmicrobial arrays, Unbiased 
next generation sequencing (NGS) and Metagenomics during the 2000s 
(Woolhouse et. al, 2012).  
 
2.5.1 What are Viruses? 
          Unable to reproduce by itself, virus is a small parasite that infects a 
susceptible cell inducing the cell to act as a machine to generate more 
viruses of the kind. Viruses can range in its complexity with the simplest 
form only being able to encode four proteins and the most complicated 
ones up to 200 proteins. Their genetic material is either RNA or DNA 
(Krulik et. al, 1999)  
          The active and infectious component of the virus is termed virion and it 
consists of the nucleic acid with an outer coat of protein. These proteins, or 
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capsid, can be in the form of replicates of one protein or an amalgamation 
of various types of proteins. The entire particle containing the nucleic acid 
and the capsid is termed nucleocapsid. In some cases, the nucleocaspid is 
further protected by an external envelope mainly formed by a phospholipid 
bilayer containing types of glycoproteins encoded by virus. This essential 
feature of viruses mimicks the phospholipids in the infected host cell’s 
plasma membrane and is formed by the budding act with the host cell’s 
plasma membrane (Maramosh et. al).  
 
2.5.2 Properties of Viruses 
 
The nucleocaspid adds to one of the key properties of viruses which is its 
protection from outside environment that would otherwise  quickly 
degrade the viral genome. The unprotected viral genome is susceptible to 
physical, chemical and enzymatic damages. It is sensitive to the extent that 
the breakage of a single phosphodiester bond may inactivate a virus.  
 
Recognition and interaction with the host cell is another key property and 
may be performed through either the protein capsid or virally encoded 
glycoprotein coat acting as spikes to enter the host cell.  
 
Viruses with small viral genomes such as poliovirus can self assemble. The 
process of self assembly of viruses require minimal energy and, in addition, 
is reversible resulting in a stable structure capable of assembling and 
disintegrating itself according to prompts.  
In order to avoid errors caused by DNA/RNA replication, transcription and 
protein synthesis stages, a viral genome is restricted to code for only a 
particular number of proteins depending on the size of the viral genome. 
Hence the accuracy of protein coding performed by the viral genome 
represents high fidelity.  
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Economy in genome-coding capacity is controlled by the existence of 
capsomers composing a spherical structure for most volume and least 
surface area (Maramosh et. al).  
2.5.3 Mechanisms of viral entry 
Different viruses have varying preferred routes of entry to the host. They 
enter the host through the skin or mucous membranes found in the 
respiratory tract, gastrointestinal tract, genital tract or conjunctiva.  
Following entry to host, the virus replication is either localized at the site of 
entry or they spread systemically to the neighboring lymph nodes. 
Examples of localized infections may be papillomavirus, adenovirus and 
norovirus while HSV-1, HSV-2 and Enterovirus cause systemic infections.  
2.5.4 Effector immune responses against viral infections 
Non-specific defense mechanism is the first mode of encounter when a 
primary infection enters in a non-immune, susceptible host. It occurs 
within few hours and the defense consists of interferon production, 
inflammation, fever, phagocytosis, and natural killer cell activity. The 
primary infection may then be prevented or aborted. Failure of this non-
specific defense mechanism leads to the spread of the virus through local 
spread, viremia, or nerve spread, to a number of target organs, producing a 
generalized infection (Baron et. al, 1984). 
 
Production of antiviral antibody through specific immune response, and 
cell-mediated immunity takes place. The dispersed antibody response in 
serum is predominantly IgG (followed by IgM) while the local antibody 
response in secretions is predominantly secretory IgA (with some IgM). 
Antibodies either neutralize virus or destroy virus-infected cells via 
antibody dependent cell-mediated cytotoxicity or complement pathway 
(Biron et. al, 1994). In cases where virus spreads throughout the body 
through blood stream, for instance measles and polio, the serum anti-body 
counters the generalized infection.  
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In localized infections of mucosal surfaces such as respiratory tract 
infection and infection of the gastrointestinal tract, IgA antibody is much 
more important. Serum antibody may not protect against recurrence of 
latent infections, such as herpes zoster (shingles) and herpes simplex, both 
because the virus may be shielded by its intracellular location and because 
cell-mediated immunity may be the more important defense (Brenner et. al 
1991). In persistent infections, serum antibody may be responsible for 
certain long-term sequelae. 
 
In situations where antibody is unable to reach the virus, cell-mediated 
immunity is essential for the control of viral infections. Examples are 
infections involving oncogenic viruses or viruses that spread directly from 
cell to contiguous cell. Cell mediated immunity specializes in recognizing 
the virally induced antigens on the surface of the infected cell, to tackle the 
infection (Hirsh et. al 1980). Cytotoxic T cells are a type of effector cells that 
fulfill this task. 
 
When the virus reaches target organs, it becomes much more complex. 
Then the host defense plays an important role causing inflammation, fever, 
and interferon production and cell-mediated immunity (Rouse et. al, 1988).  
 
2.5.5 Role of immune system in chronic HSV infections 
Herpes simplex virus (HSV) is a human pathogen belonging to the family 
Herpesviridae. There are two serotypes of the alpha herpes viruses: HSV-1 
and HSV-2. They are the causative agents of the highly prevalent oral and 
genital herpes. Not only the immune response to these pathogens is 
complex and multifactorial but also, these viruses have multiple viral 
evasion mechanisms. To understand antiviral immunity and viral 
pathogenesis, it is thus vital to the study of anti-HSV immune responses.  
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Both innate and adaptive immune mechanisms are involved in the immune 
response against HSV. However, the innate antiviral response plays a 
pivotal role in consequent the outcome of the HSV infection. Production of 
type I interferon (IFN - IFNα and IFNβ) has shown to protect against HSV in 
both mouse models and in human studies (Ellermann-Eriksen et. al, 1986; 
Shupack et. al, 1992; Vollstedt et. al, 2004).  
In vivo, multiple cell types have shown to contribute to the innate immune 
responses to HSV, such as natural killer (NK) cells and plasmacytoid 
dendritic cells (pDCs), NK cells are involved in cytokine production, 
recognition, and killing of virally infected cells. PDCs cells are involved type 
I IFN production in vivo (Biron et. al, 2001; Cerwenka et. al, 2001) 
Disease progression, latency and control of virus spread are controlled 
through the adaptive immune response. Neutralizing antibody levels have 
been negatively correlated with disease severity (Milligan et. al, 1995; 
Seppanen et. al, 2006) On the other hand, cellular response plays a vital role 
in the process. For instance, CD8+ T cells through the production of IFNγ is 
highly involved in antiviral defense, with (Dobbs et. al, 2005; Iijima et. al, 
2008). In the absence of other immune effectors, CD4+ T cells provide some 
degree of protection against HSV (Johnson et. al, 2008).  
 
2.5.5.1 Importance of IL-6, IL-8 and related cytokines in HSV 
infection  
Cytokines produced during the innate inflammation not only provides 
antiviral effects themselves, but also induces further adaptive immune 
response. Innate immune response acts through signaling induced by 
pattern recognition receptors including Toll-like receptors. Viral pathogens 
are perceived as hazardous by these receptors that initiates a cascade of 
signaling and resulting inflammatory response. Such signals are mediated 
by inflammatory cytokines, particularly interferons (IFN-α/β), IL-12 and 
TNF (Orange et. al., 1996). These proinflammatory molecules attract other 
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inflammatory cells into the infection area and activate antigen presenting 
cells to induce adaptive immunity.  
Moreover, human and animal herpes virus models have demonstrated 
signaling occurring number of TLRs including TLR2, which recognizes 
virion components including surface glycoproteins (Boehme et. al 2006; 
Compton et. al 2003), which pinpoints dsRNA (Iwakiri et. al 2009) as well 
as TLR9 which is responsible for the detection of genomic DNA (Lund et. al 
2003).  
Nason et. al. (2016) found a significant association between Herpes 
Simplex Virus shedding and high levels of IL-6. The increase in IL-6 in 
primary oral keratinocytes may induce shedding of HSV-1, and according to 
Nason et. al (2016) the increased IL-6 may also prevent subsequent 
reactivation of the virus as long as the immune-environment remained 
optimal for this cause.  
Interestingly, Donnarumma et. al (2010) found an increase in IL-l B, 
IL-6, IL-8, TNF-alpha, (i.e proinflammatory cytokines) in epithelial cells and 
concluded that their method of HSV-1 treatment indeed facilitates and 
triggers the proinflammatory immune response in HSV-1 infection. 
Additionally, the importance of targeted immune responses in different 
stages of the infection is also stressed. 
As previously mentioned about the ability of IL-6 to further modulate 
IFNs, a cytokine highly equipped with antiviral effects, McLoughlin et. al 
(2003) has found an interplay between levels of IL-6 and IFN-gamma 
during acute inflammation, which consequently has an immediate effect in 
innate immune response through recruitment of neutrophils to the site. IL-
6 has shown to attenuate neutrophil influx due to IFN-gamma, while IFN-
gamma has also shown to modulate IL-6 signaling through its soluble 
receptor (sIL-6R) to promote their apoptosis and clearance. This cyclic 
interplay dominates immune response against HSV infections. 
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2.6 Methods for Determination of Cytokine Concentration  
 
An emerging demand for rapid, precise and cost-effective quantification of 
soluble cytokines and other analytes in serum, is evolving in research 
laboratories as it is an essential factor in the management of diseases (Elshall et. 
al 2007)  
 
Quantification of cytokines as an indication of immune response can be 
performed in a number of methods. These include Enzyme Linked 
Immunosorbant Assay (ELISA), Western Blot and Multiplex Bead-based 
Immunoassay. While the most classic and standard method of cytokine 
quantification from cell supernatant is ELISA followed by Western Blot, they are 
not suitable for high throughput multiplex assays Multiplex Bead-based 
immunoassay is becoming more common due to its advantages over the former 
methods.  
 
In brief, the working mechanism of ELISA involves coating microtitre plates with 
antibodies to capture the protein of interest. Then the protein sample is added 
followed by the addition of a secondary antibody to the same antigen and 
probing for that secondary antibody.  
 
Western Blot involves resolving the proteins by size on a protein gel, 
transferring them to a membrane and probing with an antibody to the protein of 
interest.  
 
Multiplex Bead-based immunoassays work on a capture-detection sandwich-
type assay using fluorescent microspheres analyzable by Luminex instruments 
or flow cytometers (Moncunill et. al 2014).  
 
Up to 30 different proteins can be quantified with a 50 microlitre sample with 
bead-based immunoassay without losing sensitivity, accuracy, or reproducibility 
(Castillo et. al 2012), while only 1 protein can be quantified with 100 to 200 
microlitre sample with ELISA/Western Blot. Thus, the sample volume required is 
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tentatively one sixth the quantity necessary for ELISA assays due to the detection 
of six proteins in one sample. Furthermore, in preparation of the standard, a 
single set of diluted standards is used to generate a standard curve for each 
analyte.  A bead-based  experiment takes less time than a single ELISA while 
providing results that would normally require six ELISA experiments. 
In terms of the comparison of results obtained from these methods, there is a 
need to know how comparable these two methods are for quantitative analyses. 
Specific aspects of these assays, such as the clones of monoclonal antibodies used 
for detection and reporting, are crucial in producing comparable results from 
both assays. Two commercially produced bead array kits were compared with 
ELISA (DuPont et al. 2005) demonstrating considerable correlations between 
ELISA and Luminex for seven cytokines (IL-1β, IL-4, IL-5, IL-6, IL-10, IFN - 
gamma and TNF-alpha), fair correlations for IL-13, and a poor correlation in the 
case of IL-12. 
A larger study of more than 2000 serum specimens, compared multiplex bead 
based assays with ELISA to determine its potential as a replacement for ELISA 
techniques, finding that the multiplex results were, on average, 2.36-fold higher 
than ELISA values (Ray et. al 2005). 
As a solution, using identical capture and reporter antibodies, similar diluents 
and serum blockers will minimize the deviations between the two methods.  As 
these factors also vary between different vendors of multiplex bead assay kits, 
multiplex bead assay kits should not be considered interchangeable (Elshal et. al 
2007) 
 
By thorough consideration of the above variables, it is possible to use multiplex 
bead array assays in place of ELISAs particularly for research demanding high 
throughput analysis of numerous analytes. 
 
Throughout our research BD Cytometric Bead Array (CBA) Human inflammatory 
assay was used to quantify the cytokine concentrations. 
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Table 2.1: Marine-derived therapeutic compounds. 
 
Name of Drug Marine source Target Disease Nature of compound 
Molecular 
weight (g/mol) Molecular formula 
Manoalide 
South Pacific 
sponge, Luffariel
la variabilis 
Anti-inflammatory and 
analgesic properties in 
addition to its antileukemic 
and antifungal properties 
Sesterterpenoid 416.55034  C25H36O5 
IPL-576092  
Marine sponge 
Petrosia 
contignata 
Antiasthma 
Contignasterol 
(polyhydroxylated 
sterols) 
1157.40804  C48H56N10O12S6 
CGX-
1007dictyodendrins 
Fish-hunting 
snail, Conus 
geographus 
 Ischemic and excitotoxic br
ain injury, 
neuronal apoptosis, 
pain, epilepsy, and as a 
research tool in drug 
addiction and Alzheimer's 
disease 
17 amino acid peptide 
Conantokin 
2264.21  - 
GTS-21 (aka DMBX) 
Amphiporous 
lactifloreus 
 Alzheimer's disease, 
nicotine dependence, and, 
most significantly, 
for schizophrenia. 
3-(2,4-dimethoxy-
benzylidene) 
anabaseine 
308.374 C19H20N2O2 
CGX-1160 
Conus 
Geographus 
Pain and epilepsy  - 2038.20926  C89H144N20O34 
Ascididemnin 
Didemnum sp. 
tunicate 
Colon cancer, breast cancer 
and leukemia 
 Pyridoacridine 
alkaloid 
283.28356  C18H9N3O 
Salicylihalimides A 
Marine sponge 
Haliclona 
Melanoma 
Benzolactone 
enamide 
439.544  C26H33NO5 
Thiocoraline 
Micromonospor
a sp from marine 
soft coral in 
indian ocean 
from the 
myceliumof a 
Anti tumor 
Cyclic 
thiodepsipeptide and 
2-fold symmetric or 
pseudosymmetricbicy
clic octadepsipeptides 
that include the well-
 -  - 
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marine 
actinomycete, 
Micromonospor
a 
 sp.  
known qui-noxaline 
antibiotics triostin A 
and echinomycin 
Sarcodictyin 
Sarcodictyon 
Roseum, 
Eleutherobia 
aurea, Bellonella 
albiflora 
Ovarian cancer, leukemia 
2,11-cyclized 
cembranoid 
diterpenoid 
(diterpene glycoside) 
496.59524  C28H36N2O6 
Eleutherobin 
Eleutherobia 
species (possibly 
E. albiflora, 
Alcyonacea, 
Alcyoniidea) 
Various types of cancer Diterpene glycoside 656.76302  C35H48N2O10 
Peloruside A 
Mycale 
hentscheli 
Mainly ovarian cancer 
Macrolide (organic 
heterobicyclic) 
548.66342  C27H48O11 
Diazonamide 
Colonial ascidian 
Diazona 
angulata 
Cancer Single atropisomer 765.64056  C40H34Cl2N6O6 
Curacin A 
Lyngya 
Majuscula 
Renal colon and breast 
cancer 
 Jamaicamide, 
mupriocin, and 
pederin  
373.5951  C23H35NOS 
Laulimalide 
Cacospongia 
mycofijiensis 
Cancer Macrolide 514.65028  C30H42O7 
Vitilevuamide 
Didemnum 
cuculiferum and 
Polysyncranton 
lithostrotum 
Anti tumour and anti cancer 
Bicyclic 13 amino acid 
peptide 
 - C77H114N14O21S 
KRN-7000 
Okinawan 
marine sponge 
Agelas 
mauritianus. 
KRN7000 is no 
longer extracted 
from the native 
source, but 
Anti tumor activity 
infectious diseases, 
autoimmune disease and 
graft verse host disease 
Agelasphins 
(glycosphingolipids),α
-galactosylceramide 
858.322 C50H99NO9 
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chemically 
synthesized. 
Squalamine 
Squalus 
aquanthius 
Eye disorders, ovarian 
cancer continue 
Aminosterol (steroidal 
Alkaloid) 
 627.962  C34H65N3O5S 
HTI-286 
(hemiasterlin 
derivative) 
Hemiasterella 
minor 
Prostate cancer Tripeptide 473.64802  C27H43N3O4 
ES-285 (spisulosine) 
 Spisula 
polynyma or 
polynoma 
Antitumour activity variety 
of malignancies,  ranging  
from  hematological 
malignancies  to  solid  
tumors 
Phospholipid 
sphingosine 
285.50836  C18H39NO 
Discodermolide 
 Discodermia 
dissoluta 
Breast, ovarian and colon 
cancer 
Polyketide 593.7917  C33H55NO8 
E7389 (erybulin 
mesylate) 
 In 
the Halichondria 
genus 
of sponges 
Breast cancer, 
osteosarcoma 
Macrocyclic ketone 
(synthetic) 
halichondrin B  which 
is a polyether 
macroalide(natural) 
826.00222  C41H63NO14S 
Kahalalide F 
Elysia Rufescens 
(but might get it 
from the feed 
algae) 
Cancer and psoriasis  Cyclic depsipeptide 1477.87126  C75H124N14O16 
ILX 651 (Tasidotin 
Hydrochloride) 
an orally active 
synthetic 
microtubule-
targeted 
derivative of the 
marine 
depsipeptide 
dolastatin-15 
Breast cancer Pentapeptide 643.30106  C32H59ClN6O5 
Bryostatin 1  Bryozoan  
 Anti-cancer and Anti-
AIDS/HIV 
Macrocyclic lactone  905.03262  C47H68O17 
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Cryptophycins (also 
arenastatin A) 
Cyanobacteria 
Nostoc sp.  
 - Macrolide 606.70588  C34H42N2O8 
Aplidine 
Aplidium 
albicans 
Pancreatic, stomach, 
bladder, and prostate 
cancers-Antitumor Anti 
leukemic 
Peptide (cyclic 
depsipeptide) 
1110.33858  C57H87N7O15 
Girolline 
 Cymbastela 
cantharella 
Anti tumour 
2-aminoimidazole 
derivative 
190.63074  C6H11ClN4O 
Ecteinascidin 743 
Ecteinascidia 
turbinata 
Ovarian cancer 
Tetrahydroisoquinolin
e alkaloid 
761.83722  C39H43N3O11S 
Didemnin B 
 Tunicate (sea-
squirt) of 
the genus Tridid
emnumSolidum (
family 
of Didemnidæ 
 Adenocarcinoma of 
the kidney,[4]advanced epit
helial ovarian cancer,[5] and 
metastatic breast 
cancer.[6]  
 Cyclic depsipeptide 1112.35446  C57H89N7O15 
Soblidotin 
Dollabella 
Auricularia 
Anti tumour and vascular Peptide 701.97918  C39H67N5O6 
Dolastatin-10 
 Sea hare 
Dolabella 
auricularia, and 
we now report 
its isolation from 
the marine 
cyanobacterium
Symploca sp. 
VP642 from 
Palau 
Anti cancer Pentapeptide 785.09092  C42H68N6O6S 
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Table 2.2: Immunomodulatory compounds from marine species 
Marine Source Immunomodulatory Compound(s) 
Shark  Shark Liver Oil, Shark Cartilage, Squalamine 
Red Seaweed peptides and polysachcharides 
Marine Fungus: Phoma Herbarum 
YCP Alpha-D-glucan (polysachacharides of D 
glucose monomer)  
Kuruma Shrimp Lactic Acid Bacteria from shrimp intestine 
Fermented marine Alga Bacillus subtilis 
Brown Algae Fucoidan 
Hydrothermal Vent bacteria 
Over-sulphated low molecular 
exopolysachcharide 
Oyster (Crassostrea hongkongensis) Peptides OPENF 
Marine Bacteria: Pseudoalteromonas strains  Lipopolysachcharide 
Marine microalgae: Sarcinochrysis marina Geitler Degraded polysachcharide (SMP) 
 Marine algae Solieria filiformis (SfL), Pterocladiella 
capillacea (PcL) and Caulerpa cupressoides (CcL) 
Lectins 
fish oil n-3 polyunsaturated fatty acids 
Jellyfish: Chironex fleckeri Cnidarians 
Red Algae: Halopithys incurva and Hypnea spinella  Polysachcharides 
Brown Algae 
Hyposulfated (hypoS), deacetylated (deAc), and 
both hyposulfated and deacetylated 
(hypoSdeAc) derivatives of native Fucus 
evanescens fucoidan 
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Marine sponges 
Callyspongidiol and 14,15-dihydrosiphonodiol 
are Polyacetylenediols 
Marine snail: Telescopium telescopium 
Cytosol fraction of spermatheca and/or the 
ovotestis 
red alga Mastocarpus stellatus Floridoside 
Marine algae Sulfated polymannuroguluronate (SPMG) 
Fresh water blood cyanobacterium Microcystins (MCs) 
Marine fish oil Polyunsaturated fatty acid n-3 
Bugula neritina Bryostatin 1 
Tunicates: Didemnidae Didemnins 
Lichen polysachcharides 
Starfish Five new steroid glycosides, luzonicosides B-E  
Limpet Fissurella latimarginata Hemocyanin 
gastropod Rapana thomasiana  Hemocyanin 
Styela Clava 
(1) Cholesteric-7-en-3 beta-ol, (2) cholesteric-4-
en-3 beta,6 beta-diol, (3) cholesterol, (4) batilol, 
and (5) ceramide 
Soft coral: Lobophytum crassum, 
Immunomodulatory effects 
of marine cembrane compounds, (9E,13E)-5-
acetoxy-6-hydroxy-9,13-dimethyl-3-methylene-
3,3a,4,5,6,7,8,11,12,14a-decahydro-2H-
cyclotrideca[b]furan-2-one , (9E,13E)-5-acetoxy-
6-acetyl-9,13-dimethyl-3-methylene-
3,3a,4,5,6,7,8,11,12,14a-decahydro-2H-
cyclotrideca[b]furan-2-one , lobocrassin B , (-) 
14-deoxycrassin, cembranolide B  and 13-
acetoxysarcocrassolide  
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3.0 Introduction 
 
 
Naturally derived compounds as potential drug candidates have been growing 
increasingly in research interest throughout the world. Particular interest lies in 
marine derived compounds, since the pool of a staggering 700,000 species rests in 
the marine world and varied spectrum of potential compounds promises healing 
and disease prevention, largely due to their successful existence over millions of 
years despite inhabitancy with harmful viruses and bacteria present in the marine-
environment.  
 
A valuable nature of certain marine-derived compounds is their immunomodulatory 
properties. This is mainly not only due to the lack of abundance in 
immunomodulatory synthetic drugs in the market, but also due to the near 
negligible side effects of marine-derived drugs (Nair et. al, 2015). Additionally, the 
cost of such compounds is much lower than synthetic compounds. 
Immunomodulatory drugs can be used to treat a broad range of major chronic 
diseases such as: Alzheimers disease, diabetes, Parkinson’s disease, multiple 
sclerosis, herpes simplex infections, HIV/AIDs, etc. Thus, the vast need for 
immunomodulatory drugs in the medical field, combined with much lessened cases 
of side effects from marine derived compounds and their low cost attributes, the 
benefits are extraordinary. 
  
In this study, we focus on the immunomodulatory properties of the hemolymph 
from the abalone species Haliotis rubra. Immunomodulatory effects are assessed on 
human immune response in vitro in three different cell lines. The level of cytokine 
modulation acts as the indication of immunomodulation effectiveness.  
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3.1 Materials 
 
HaCat cells (spontaneously immortalized human keratinocytes) were kindly 
provided by Junlae Cho (Department of Pharmacy, University of Sydney) and they 
were propagated in Gibco Dulbecco’s Modified Eagle’s Medium (DMEM Glutamax) 
supplemented with 10% Fetal Bovine Serum (FBS). PC-3 cells were kindly provided 
by my colleague Mr. Balakrishna Shammugaswami and they were propagated in 
Gibco RPMI 1640 medium supplemented with 10% Fetal Bovine Serum (FBS). Both 
the media along with DPBS Buffer solution were sourced from ThermoFisher while 
the FBS was supplied by Sigma-Aldrich. Human Oral Primary Keratinocytes (HOK 
Cells) were purchased from ABMGood (local agent: Resolving images Australia) and 
they were propagated in the PriGro X cocktail medium on poly-l-lysine coated T75 
flasks sourced from the same source. Cytotoxicity was assessed with Cell Counting 
Kit (CCK-8 reagent) supplied by Sigma Aldrich. Cytokine level changes were 
determined with the use of BD Human inflammatory Cytokine Cytometry Beads 
Array (CBA) kit, Calibrite 3 BEADS for flowcytometer and FCAP Array software that 
were all purchased from BD Biosciences Australia. For propagating the primary 
keratinocytes Trypsin Neutralizing Solution (TNS) was purchased from Lonza, 0.1 M 
pH 7.4 Tris Buffer solution was sourced from Astral Scientific.  Poly-l-lysine solution 
bioreagent 0.01% (mol wt 70,000- 150,000 Da) were used for coating to aid cell 
adhesion and was supplied from Sigma Aldrich. Trypsin and DMSO required for cell 
propagation were also purchased from Sigma Aldrich. Trypan Blue (Gibco) was used 
during cell counting along Qbit assays from Invitrogen were used for protein 
concentration quantification.  Fresh abalone sera was kindly provided by Marine 
Biotechnologies Australia which was then centrifuged in Biofuge Stratos sterilized 
with  Millipore  0.22μm vacuum driven filtration.  Purification of the hemocyanin 
was achieved with Ultra-4 Centrifugal Filter Units (100 KDa, Millipore).  
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Table 3.1: Cell culture protocol followed for HaCat cells, Human Oral Keratinoctyes and PC-3 cells in propagation, passage and 
freezing.  
  HaCat Cells Human Oral Keratinocytes PC-3 Cells 
Propagation 
       Media Used DMEM PriGroX RPMI 1640 
% FBS in Media 10 Serum-free 10 
Type of flask used T75 2 μg/cm2 Poly-l-lysine coated T75 T75 
% Anti-biotic 0 0 0 
Vol of media per 
flask 14 20 12 
Seeding cell density 1 x 10 6 1 x 10 6 1 x 10 6 
Cell adhesion to flask  12 hours 10-12 days 12 hours 
Cell confluence  48 hrs 14 days 48 hrs 
    Passage 
       Confluence at 
passage 70% 90% 70% 
Passage frequency 2.5 days 14 days 2.5 days 
Wash Buffer DPBS DPBS DPBS 
Trypsin Volume 2 ml 2 ml 2 ml 
Trypsin Dilution? no diluted in 8 ml DPBS no 
Trypsin Neutralizer? only media Trypsin Neutralizing Solution (TNS) only media 
Passage ratio 1:3 1:2 1:3 
    Freezing  
       Cell density 1 x 10 6 1 x 10 6 1 x 10 6 
Freezing Media 20% FBS & 10%DMSO 70% Media, 20% FBS and 10% DMSO 20 %FBS & 10%DMSO 
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3. 2 Methodology 
 
3.2.1 Cell Culture Protocol 
 
Cell culture protocols of HaCat and PC-3 cells were similar and followed the 
regular procedure for propagation, passage and freezing. Human Oral 
Keratinocytes, however required a more sensitive procedure. Poly-l-sine 
coated T75 flasks were required for propagating these cells, Trypsin was 
required to be diluted with DPBS2:8 ratio, and trypsin neutralizing solution 
was required to deactivate the trypsin following 1 to 2 minute incubation. 
The deactivated cell suspension solution in the passage was transferred to 
5ml FBS prior to centrifuge and final transfer to PriGroX Media.  
3.2.2 Coating of Cell culture plates with Poly-l-lysine 
 
While Poly-l-lysine coated T75 flasks were purchased (ABM Good), cell 
culture 6 well plates and 96 well plates needed to be manually coated for the 
Human Primary Oral Keratinocytes plate attachment. The required 
concentration of Poly-l-lysine was 2 μg / cm2 . This was done 24 h prior to 
cell seeding. 
  
For 6 well plates: 
 
384 μL of poly-l-lysine solution was added to each well and gently rocked to 
ensure entire surface area was covered per well.  
 
For 96 well plates: 
 
14 μL of poly-l-lysine solution was added to each well and gently rocked to 
ensure entire surface area was covered per well. 
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The plates were then incubated for 5 minutes followed by complete aspiration. Each 
well was thoroughly rinsed with sterile tissue culture grade water and allowed to 
dry for at least 2 hours before use.  
 
 
3.2.3 Determination of required seeding cell density of HaCat cells per well in 
6 well plates: 
200 μl pipette tips were autoclaved for sterilization and used to seed passaged 
HaCat cells in triplicates of varying concentrations in the range 10,000, 20,000, 
30,000, 40,000, 50,000, 100,000, 150,000 200,000, 250,000 and 300,000 cells per 
well in four 6 well plates. The cell confluence was observed and reported for 72 
hours to determine the appropriate seeding cell density with 90% confluence at 72 
hour mark. This was required according to the timing of subsequent experiments.  
3.2.4 Cytotoxicity Test standard curve  
Cells were recovered from  T75 culture flask after trypsinization, counted with a 
hemocytometer and the concentration adjusted to 5 x 10 4 cells per ml. 100 µl of 
media was added to each well of 96 well plates and triplicate serial dilutions of 
variable cell concentrations were performed (2.5x104 , 1.25x104 and 6.25x103). The 
96 well plate was then incubated for a period of 24 and 48 hours in a CO2 incubator.  
10 µl of Cell Counting Kit- 8 (CCK-8) was added to each well. The microplates were 
incubated for 1 h, 2 h, 3 h and 4 h time slots. Using spectrophotometer, colorimetric 
reading was taken using a filter for 450 nm. The optimum seeding cell density for 
each cell type was determined. The optimum CCK-8 incubation time was also 
obtained from the standard curve generated (absorbance vs number of cells).  
3.2.5 Determination of the cytotoxicity of Abalone sera, purified hemocyanin 
and permeate on HaCat cell line and PC-3 cell line 
The effect of AH, sera and sera permeate on cell viability was assessed using CCK-8 
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assay to determine the highest concentration, which could be tolerated by the HaCat 
cells and PC-3 cells in the subsequent assay. The experimental set up of the plates is 
illustrated in Fig. 3.1.  
Cells were recovered from  T75 culture flask after trypsinization, counted with a 
hemacytometer and the concentration adjusted according to findings from the 
standard curve. 100 µl of media was added to each well of 96 well plates containing 
triplicates of 2000 cells per well. The 96 well plate was then incubated for a period 
of 24 hrs to allow the cells to attach to the plate.  The media was then discarded, and 
100 µl  fresh media was added to each well, including triplicate of negative control 
wells. 10 µl of test extract (sera, purified hemocyanin and permeate) were added in 
variable concentrations, and incubated for set periods (depending on the 
experiment performed ranging from 30 mins to 72 hrs). 10 µl of Cell Counting Kit- 8 
(CCK-8) was added to each well and incubated for 1 h, followed by absorbance 
reading in the spectrophotometer at 450 nm.  
 
 
Figure  3.1: Experimental setup of cytotoxicity determination: bird’s eye view of the 
96 well plate. 
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3.2.6 Extraction of Fresh Sera (hemolymph) from the Abalone 
 
Haliotis rubra (black lipped abalone) was meticulously selected and those without 
scars and signs of disease were gathered from Tasmanian coastline bays by Marine 
Biotechnologies Australia Pty Ltd, followed by 5 days of conditioning in their 
factory, in recirculating salt water system (in 14 °C and 33 parts per thousand 
salinity). Prior to extraction of sera, prevention of bacterial contamination was 
ensured through spraying of the abalone with 0.2 μm filtered salt water. The animal 
was then rested at an angle of 30 ° to allow for drainage of excess water.  
The abalone was then positioned shell side down at a 45° angle, 400 mm height 
above the extraction surface. The extraction was performed with a Terumo Surflo 
LV catheter with dimensions 14 g x 1.73 id x 51 mm, which was inserted at a long 
axis angle of 40° behind the abalone’s neck. The soft outer catheter plastic was left 
behind as the internal needle of the catheter was removed immediately. The outer 
catheter was then gradually withdrawn until the cephalic arterial sinus was 
intersected. Around 10 mL hemolymph was drained to waste, and a sterile silicon 
tube was attached to the catheter’s end to act as the transport vessel to a sterile 
container. Approximately 150 mL of hemolymph can be safely collected without 
causing mortality to the animal (Dr. Valtchev, 2015, priv. comm.).  
3.2.7 Filtration and Sterilization of the Fresh Sera (hemolymph) 
Upon reaching Professor Dehghani’s lab at Sydney University, the hemolymph was 
then centrifuged (Biofuge stratos) at 4000×g for 15 min to remove hemocytes and 
debris. The hemolymph was sterilised using vacuum driven filtration (0.22μm, 
Millipore) and stored at 4°C for experimental use. Sterilization was required to 
prevent any bacterial contamination that may degrade hemocyanin. 
 
 
 50 
3.2.8 Purification of Abalone Hemocyanin using ultrafiltration 
Ultrafiltration was performed using Ultra-4 Centrifugal Filter Units (100 KDa, 4 mL, 
Millipore) (Illustrated in Fig. 3.2).  
4 mL sterile grade water was centrifuged at 4000 x g for 3 minutes at 4 °C to wash 
the filter and to let the centrifuge reach the low temperature setting. The water was 
then discarded and 4 mL sera was centrifuged at 4000 x g for 20 minutes at 4 °C. 
The permeate was then collected and protein concentration determined using Qubit 
assay. The retentate (purified hemocyanin) was topped up with Tris Buffer (0.1 M 
7.4 pH) to match the initial total volume of 4 mL. Tris buffer was used because of its 
useful buffer range of pH 7-9, which mimics the physiological pH typical of most 
living organisms.  
 The protein concentration was determined using Qbit assay. Table 3.2 notes the 
dilution measurements for each concentration of extracts. Subsequent dilutions of 
the purified hemocyanin and permeate (containing smaller peptides) were 
performed using Tris buffer (either 4 mL or 2 mL) to achieve various concentrations 
of the purified hemocyanin and permeate.  All samples were incubated on ice to 
prevent protein disintegration prior to experiments. 
Table 3.2: Dilutions of the purified hemocyanin and permeate following 20 minute 
centrifugation at 4000 x g, 4°C 
  
Concentration 
(μg/mL) 
Vol. of Tris buffer 
added for dilution 
   Purified 
hemocyanin 
2.3 x 10 3 4 mL 
 
1.3 x 10 3 8 mL 
   Permeate 556 0 mL  
 
398 4 mL 
 
63 6 mL 
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Tris Buffer added to dilute permeate 
Tris Buffer added to dilute 
hemocyanin 
Tris Buffer added to achieve 
initial volume 
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Figure 3.2: Partial purification and dilution of hemocyanin by ultrafiltration using 
filters with Molecular weight cut off of 100 kDa (used to separate the hemocyanin 
molecules which are much larger in size than this cut off) and Tris buffer. Impurities 
were eluted with ultrapure water.  
 
3.2.9 Determination of Protein concentration using Qubit 
 
Qubit assay (Invitrogen) was found to be the most appropriate (reproducible and 
accurate) method of protein quantification compared to Bradford assay and BCA, 
according to Dr. Zanjani (Thesis, 2014). Therefore protein concentration 
quantification was performed using Qubit, which yields a fluorometric quantitation 
of protein content. Measurments are based on the signals emitted when the 
fluorescent dye binds to the protein. It is a highly sensitive assay.  
Three assay tubes were set up for standards, and one tube for each sample i.e three 
for permeate samples and two for hemocyanin samples. Qubit reagent was diluted 
200 times in Qubit buffer solution to prepare the working solution. Three pre-
diluted BSA standards (Invitrogen) were used for the calibration of instrument 
(Qubit® 2.0 Fluorometer, Invitrogen). The dilution measurements are outlined in 
Table 3.3 below. 
Various dilutions of protein samples according to (Table: Dilution of the purified 
hemocyanin and permeate following 20 minute centrifugation at 4000 x g, 4°C) 
were further diluted in 0.5-mL optical-grade real-time PCR tubes, with the working 
solution according to the following table and incubated in dark at room temperature 
for 15 minutes after vortexing all tubes for 2 to 3 seconds.  
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Table 3.3: Dilutions carried out on variable concentration samples of purified AH 
and permeate to assess the concentration using Qubit 2.0 Fluorometer. 
  
Hemocyanin 
1  
Hemocyanin 
2 
Permeate 
1 
Permeate 
2 
Permeate  
3   
Vol. of working 
solution 198 μL 198 μL 190 μL 190 μL 195 μL 
 Vol. of sample 2 μL 2 μL 10 μL 10 μL 5 μL 
 Total Vol.  200 μL 200 μL 200 μL 200 μL 200 μL 
   
     
 
 
Using the Qubit fluorometer, the absorbance values of standards and samples were 
measured.  The concentrations of the protein samples containing hemocyanin and 
permeates were then calculated using the following equation: 
 
 
 
3.2.10 Incubation with the test extracts 
Immunological effects of the abalone sera, purified hemocyanin and small peptide 
containing permeate were to be observed on various cell types including Human 
oral primary keratinocytes, HaCat Cells and PC-3 Prostate cancer cells. This required 
various experimental designs to find the optimum incubation time, type of extracts 
and concentration. We tested for various parameters in the initial experiments to 
optimize the experimental design for highest practically obtainable cytokine yield 
from treatment with extracts. Varying the dosage gave us an ideal dosage % of sera, 
high cell density helped us obtain the appropriate in vitro model and the different 
time points indicated the optimum treatment time in vitro. In the results section of 
these treatment experiments the error bars are +- SD. Some of the treatments are 
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conducted in n=3, while others are n=2 and n=1. This depended on the importance 
of the treatment and dose dependent effects noted.  
 
3.2.10.1 Incubation of test extracts with HaCat Cells  
 
HaCat cell line was used to develop the protocol for test extract incubation 
and cytokine detection.  
 
(i) Short time span incubation of low cell density wells with low 
concentration range sera: 
 
Passage 15 cells (passaged from 70% confluent T75 cell culture 
flasks) were counted using a hemocytometer and seeded at 3200 cells 
per well of 12 well plate dishes and allowed to adhere to the plate for 
24 hours. Sera concentrations of 1%, 5%, 10% and 20% v/v were 
injected and incubated for 1 h, 2 h and 5 h . Serum free media was 
used as triplicate controls.  
 
(ii) Instantaneous immune response with low cell density and fixed 
concentration of sera  
 
Passage 17 cells (passaged from 70% confluent T75 cell culture 
flasks) were counted using a hemocytometer and seeded at 3200 cells 
per well of 12 well plate dishes and allowed to adhere to the plate for 
24 hours. Sera concentration of 5% v/v were injected in triplicate 
wells and incubated for 15 min, 30 min and 45 min. Undisturbed 
control was used to prevent immune reaction of cells caused by 
turbulence of the surrounding. Two independent experiments were 
conducted in triplicates. 
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(iii) High cell density, low sera concentration and short time span study of 
immune response 
 
Passage 15 cells (passaged from 70% confluent T75 cell culture 
flasks) were counted using a hemocytometer and seeded at 135,000 
cells per well of 6 well plate dishes and allowed to adhere to the plate 
for 24 hours. Sera concentration of 2% v/v were injected in triplicate 
wells and incubated for 30 min, 1.5 h and 2.5 h 
Serum free media was used as control. Additional undisturbed 
controls were also used. Two independent experiments were 
conducted in triplicates. 
 
(iv) High cell density, high sera concentrations and long incubation time 
study of immune response 
 
Passage 15 cells (passaged from 70% confluent T75 cell culture 
flasks) were counted using a hemocytometer and seeded at 135,000 
cells per well of 6 well plate dishes and allowed to adhere to the plate 
for 24 hours. Sera concentrations of 10 % and 20% v/v were injected 
in triplicate wells and incubated for 16 h. Serum free media was used 
as control. Two independent experiments were conducted in 
triplicates. 
 
(v) High cell density, purified hemocyanin test extract and long 
incubation time study of immune response 
 
Passage 15 cells (passaged from 70% confluent T75 cell culture 
flasks) were counted using a hemocytometer and seeded at 135,000 
cells per well of 6 well plate dishes and allowed to adhere to the plate 
for 24 hours. Purified hemocyanin (using ultrafiltration according to 
the protocol stated previously) at concentration of 20% v/v was 
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injected in triplicate wells and incubated for 16 h. Serum free media 
was used as control. Two independent experiments were conducted 
in triplicates. 
 
 
(vi) High cell density, ultrafiltered sera permeate test extract and long 
incubation time study of immune response 
 
Passage 15 cells (passaged from 70% confluent T75 cell culture 
flasks) were counted using a hemocytometer and seeded at 135,000 
cells per well of 6 well plate dishes and allowed to adhere to the plate 
for 24 hours. Ultrafiltered hemolymph permeate at concentration of 
20% v/v was injected in triplicate wells and incubated for 16 h. Serum 
free media was used as control. Two independent experiments were 
conducted in triplicates. 
 
(vii) 6 day dosage basis incubation with high sera concentrations – study of 
immune response 
 
Passage 15 cells (passaged from 70% confluent T75 cell culture 
flasks) were counted using a hemocytometer and seeded at 35,000 
cells per well of 6 well plate dishes and allowed to adhere to the plate 
for 24 hours. 10% and 20% v/v sera concentration were injected each 
day, incubated for 1 to 2 hrs. The media (including the test extract) 
was then removed completely and replaced with fresh media. This 
was repeated for 6 days, while the 6th day incubation time was 5 h. 
Experimental procedure for this experiment is illustrated in Fig. 3.3 
below. 
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Figure 3.3 : Experimental procedure for incubation for the 6 day treatment of HaCat 
cells.  
 
 
 
3.2.10.2 Incubation of test extracts with Prostate Cancer Cells (PC-3)  
 
Only 1 condition for PC-3 cells as PC-3 cells are very sensitive to the 
extracts and only low treatment time of 5 hrs was sufficient for cytokine 
yield.  
 
 
(i) High cell density, ultrafiltered sera permeate test extract and short 
incubation time study of immune response 
 
Passage 13 cells (passaged from 70% confluent T75 cell culture 
flasks) were counted using a hemocytometer and seeded at 240,000 
cells per well of 6 well plate dishes and allowed to adhere to the plate 
for 24 hours. Ultrafiltered hemolymph permeate at concentration of 
20% v/v, purified hemocyanin at concentration of 20% v/v and 
abalone hemolymph at concentration of 20% v/v were injected in 
triplicate wells and incubated for 5 h. Serum free media was used as 
control. Two independent experiments were conducted in triplicates. 
 
 
 
 
Step 1: Sera 
injected each day 
Step 3: Media 
Aspirated and 
fresh media 
added back. 
Step 2:  
 
1 to 2 hr incubation 
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3.2.10.3  Incubation of test extracts with Human Primary Oral Keratinocytes  
 
In this case, we have already optimized the experimental conditions for 1 
type of keratinocytes (HaCat cells), hence we used the optimized 
condition of high cell densite, 16 hr treatment time and maximum 20% 
sera conc. 
 
(i) High cell density, high sera concentrations and long incubation time 
study of immune response 
 
Passage 3 cells (passaged from 90% confluent Poly-l-lysine coated 
T75 cell culture flasks) were counted using a hemocytometer and 
seeded at 125,000 cells per well of poly-l-lysine coated 6 well plate 
dishes and allowed to adhere to the plate for 48 hours. Sera 
concentration 20% v/v were injected in triplicate wells and incubated 
for 16 h. Tris buffer was used as control. Two independent 
experiments were conducted in triplicates. 
 
(ii) Dose dependent immune response effect of abalone sera 
 
Passage 4 cells (passaged from 90% confluent Poly-l-lysine coated 
T75 cell culture flasks) were counted using a hemocytometer and 
seeded at 102,000 cells per well of poly-l-lysine coated 6 well plate 
dishes and allowed to adhere to the plate for 48 hours. Sera 
concentration 5%, 10%, 20% and 30% v/v were injected in triplicate 
wells and incubated for 16 h. Tris buffer was used as control.  
 
(iii) Dose dependent immune response effect of purified hemocyanin 
 
Passage 4 cells (passaged from 90% confluent Poly-l-lysine coated 
T75 cell culture flasks) were counted using a hemocytometer and 
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seeded at 102,000 cells per well of poly-l-lysine coated 6 well plate 
dishes and allowed to adhere to the plate for 48 hours. Purified 
hemocyanin concentrations 2.3 x 103  μg/mL and 1.3 x 103 μg/mL 
were injected in triplicate wells and incubated for 16 h. Tris buffer 
was used as control.  
 
(iv) Dose dependent immune response effect of ultrafiltered hemolymph 
permeate 
 
Passage 4 cells (passaged from 90% confluent Poly-l-lysine coated 
T75 cell culture flasks) were counted using a hemocytometer and 
seeded at 102,000 cells per well of poly-l-lysine coated 6 well plate 
dishes and allowed to adhere to the plate for 48 hours. Permeate 
concentrations 556 μg/mL, 398 μg/mL and 63 μg/mL were injected in 
triplicate wells and incubated for 16 h. Tris buffer was used as control.  
 
3.2.11    Human Inflammatory Cytokine Beads Array 
Immunological effects of the abalone sera, purified hemocyanin and small peptide 
containing permeate were to be observed on various cell types including Human 
oral primary keratinocytes, HaCat Cells and PC-3 Prostate cancer cells.  
 
In order to quantify the immune response, Human Inflammatory Cytokine Beads 
Array was used to observe cytokine level changes pre and post incubation with the 
test extract. The CBA Kit quantitatively measures IL-8, IL 1 B, IL -6, IL -10, TNF  and 
IL 12 protein levels. It provides a method of capturing a set of analytes with beads of 
known sizes and fluorescence, enabling it to detect analytes with flow cytometry.  
 
A single capture bead is conjugated with specific antibody that forms a sandwich 
complex with the analyte and phycoerythrin detection reagent that provides a 
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fluorescent signal proportional to the amount of bound analyte. The six bead 
population has distinct fluorescence intensities and are coated with capture 
antibodies for IL-8, IL 1 B, IL -6, IL -10, TNF and IL 12 proteins. Fig 3.4 identifiest 
each of the peaks of these cytokines.   
 
 
Figure 3.4: Fluorescence peaks of six different cytokines measured in all of the 
cytometric beads array human inflammatory cytokines assay conducted.  
 
 
3.2.12  Materials for CBA Human Inflammatory Cytokine Kit 
 
The following materials were procured: 
6 vials of capture beads for each detectable cytokine ( 0.8 mL each)  
Human Inflammatory Cytokine PE Detection Reagent (4 mL) 
Human Inflammatory Cytokine Standards ( 2 lyophilized vials) 
Cytometer setup beads (0.5 mL) 
PE Positive control detector (0.5 mL) 
FITC Positive control detector (0.5 mL) 
Wash Buffer (260 mL) 
Assay Diluent (30 mL) 
Serum Enhancement buffer (10 mL) 
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3.2.13  Preparation of Standards 
 
A vial of lyophilized Human Inflammatory Cytokine standard was transferred to a 
15 mL polypropylene tube, reconstituted with 2 mL Assay diluent and marked as 
Top Standard. This was equilibrated for 15 minutes and gently mixed with pipette.  
 
12 x 75 mm tubes were labeled in descending order of standard concentrations: 1:2, 
1:4, 1:8, 1:16, 1:32, 1: 64, 1:128 and 1:256. The flow cytometric results of each of 
these standards are captured in Fig 3.6, where the increasing concentration is 
depicted by shifting of the peaks to the right.  
 
300 μL of Assay Diluent was pipetted to each of the tubes and serial dilution 
performed by transferring 300 μL from the Top Standard to the 1:2 dilution tube. 
This was mixed thoroughly with pipette and 300 μL was transferred to the 1:4 tube 
and so on until 1:256 tube was serially diluted. One tube contained only the assay 
diluent and acted as negative control. Serial dilution procedure is illustrated in Fig. 
3.5.  
 
 
 
 
 
 
 
 
 
Figure 3.5: Cytokine Standard serial dilution procedure with assay diluent. 
300μL 300μL  300μL    300μL  300μL    300μL    300μL     300μL  
 
 
 
 
  
 
 
Top          1:2         1:4         1:8         1:16       1:32      1:64       1:128    1:256 
Standard 
 62 
                         
A. B. C. 
 
 
                         
D. E. F. 
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G. H. I. 
 
 
 
J. 
 
 
 
Figure 3.6: Shift of fluorescence peaks on six cytokine standards in accordance with concentration of the standard A. 0 pg/ml 
B. 20 pg/ml C. 40 pg/ml D. 80 pg/ml E. 156 pg/ml  F. 312 pg/ml G. 625 pg/ml H. 1250 pg/ml I. 2500 pg/ml J. 5000 pg/ml 
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3.2.14 Preparation of the Assay 
 
 Number of required assay tubes was determined according to the number of 
samples, controls and standards allocating 10 μL aliquot of each capture 
bead for each assay tube after vigorously vortexing. For instance, 24 samples 
meant 240 μL of each capture bead of the six. The tube was labeled “Mixed 
capture beads”, and was thoroughly vortexed.  
 50 μL of this mixed capture beads were added to all assay tubes including the 
standard tubes.  
 50 μL of each unknown sample (cell culture supernatant from test extract 
incubated cell and media) was added to appropriately labeled tube (e.g 20% 
v/v sera incubation) 
 50 μL of Human inflammatory PE detection reagent was added to all assay 
tubes. 
 The assay tubes were incubated in dark for 3 hours, followed by pipetting of 
1 mL wash buffer in each tube and centrifugation at 200 x g for 5 minutes.  
 It was then carefully aspirated and resuspended with 300 μL of Wash Buffer. 
 
3.2.15 Flow Cytometer Setup using the Setup beads and Sample Acquisition 
 
During the incubation, the flow cytometer setup was conducted following the 
procedure below: 
 
100 μL of cytometer setup beads were added to a 12 x 75 mm sample acquisition 
tube and gently vortexed with 400 μL of wash buffer. The tube was loaded onto the 
cytometer under appropriate file and was acquired. The FSC and SSC voltages were 
adjusted until the singlet bead population fit the P1 gate in the template. The APC 
voltage was adjusted until the mean of P2 was 70,000. The PE voltage was adjusted 
until the mean of P3 was approximately 75. The FITC voltage was adjusted until the 
mean of P4 was approximately 75.  The settings were then saved to catalog under 
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the cytometer settings option.  The Assay tubes were then acquired in FACS Cantos 
II flow cytometer, after being thoroughly vortexed.  The analysis was conducted 
using FCAP Array software and graphs generated using Microsoft Excel. 
 
3.2.16 FCAP ARRAY Software 
 
Analysis of BD CBA assay acquired on the FACS Canto II flow cytometer was 
performed using this software which was specifically designed for this assay. Upon 
creating a new experiment and loading the .fcs files from acquired samples from the 
flow cytometer, “standard” “sample” and “control” labels were assigned. 
Bead model was selected and Debris filtering was performed. Beads were assigned 
to each peak and manual clustering was performed if necessary. Quality Control was 
monitored and the standard graphs were generated. Raw data of “Fitted 
concentration of each analyte or sample” were reported. The raw data achieved was 
then processed in Excel to generate graphs showcasing the results of each 
experiment. 
 
3.2.17  Statistical Analysis 
 
The results of the experiments were expressed as means±S.D. Comparisons between 
groups were made using one-way ANOVA. Statistical significance was defined at a p-
value of < 0.05.  
 
 
 
 
 
 66 
 
 
CHAPTER 4:  
 
Cytotoxicity Analysis on 
HaCat Cells & Prostate 
Cancer Cells  
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4.0 Introduction 
 
Cytotoxicity and cell viability analysis was carried out to negate the effects of the 
sera, purified hemocyanin and sera permeate on cell survival rate. In numerous 
cases the cytotoxic nature of an extract triggers several immune responses, 
particularly in keratinocytes. It is important to prove that the concentration of 
extracts used during immune studies experiments is significantly lower than the 
CC50 of the extracts. (CC50- cytotoxic concentration of the extracts at which 50% 
of the viable cells are dead). At CC50, there would be triggered immune 
responses that are not related to the anti-viral nature of the extracts. Without 
cytotoxicity test, these immune responses may be mistaken for cytotoxic effects 
of the extracts. 
  
A more common reasoning of performing cytotoxicity test is to analyse the safe 
concentrations of use of the extracts: a concentration at which it targets the virus 
without causing harm to host cells.  
 
Various incubation time periods and concentration of extract combinations were 
used in the cytotoxicity tests as outlined below. Cytotoxicity of abalone sera was 
measured with CCK-8 Assay on HaCat Cells, PC-3 Cells and Human oral primary 
keratinocytes. 
 
To the best of our knowledge there are no available literature data on the 
cytotoxicity of abalone hemocyanin, abalone sera and abalone sera permeate on 
the particular cell lines of HaCat cells, Prostate cancer cell line PC-3 cells and 
Human Oral Keratinocytes. However, studies show the cytotoxic effects of few of 
the above extracts on related cell lines. Cytotoxicity of marine snail hemocyanin 
(Rapana thomasiana hemocyanin)  with series of imidazolium-based amino acid 
ionic liquids [emim][AA] was tested on 3T3 murine fibroblasts (non-cancerous 
cells) and breast cancer cell line MCF-7 (Guncheva et. al 2016). It was found that 
the extract produced weak (10–15%) to moderate (15–20%) anti-proliferative 
effects toward MCF-7 and 3T3 cells. Additionally, HTB68 melanoma cell line 
proliferation was inhibited by 28% by KLH (McFadden et. al 2007) and the cell 
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viability of the bladder cancer cell lines 647 v, CAL 29 and T 24 after treatment 
with Helix lucorum hemocyanin (HlH) for 72 hours were 20.8 %, 59. 2 % and 
46.36 % respectively (Antonova et. al 2015). Dendritic cells pulsed with KLH 
showed a viability of 87.4 % (Teitz-Tennenbaum et. al 2008).   
 
The cytotoxic effect of abalone hemocyanin, abalone sera and abalone sera 
permeate on keratinocytes and prostate cancer cell line will thus be a novel 
study.  
 
4.1 Results 
        The cytotoxicity results are presented as absorbance values vs concentration 
of abalone sera. Absorbance is a direct indication of viability of cells (higher 
absorbance corresponds to higher cellular activity, hence higher cell viability). 
Hence viability vs concentration graph is directly comparable to the graph 
presented. In our case the graphs presented here are a better representation to 
avoid negative % and % above 100 that resulted from varying cellular 
proliferation between wells. Additionally there was no significant effect on cell 
viability in any case that would have resulted in a sensible viability graph by 
overcoming the varying proliferation issue.   
4.1.1 The effect of abalone sera and purified AH on the viability of HaCat 
cells and PC-3 cells 
Cytotoxicity of a range of low abalone sera concentrations (0.1 %, 0.5 % , 1 
% , 2 %, 5 % and 10% v/v) was tested upon incubation of HaCat cells with 
the extract for 30 min, 3 h, 4 h and 6 h time frames. Cytotoxicity at low time 
period was of particular interest to mimic the short exposure time during 
the process of abalone sera oral ingestion.  
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Figure 4.1: Effect of variable concentrations ( 0.1%, 0.5%, 1%, 2%, 5% and 10% 
v/v) of abalone sera on the viability of HaCat cells , which were treated for 30 
min, 3 hour, 4 hour and 6 hour. Absorbance detected at 450 nm.  
 
The results in figure 4.1 show that no cytotoxicity is observed for this low extract 
concentration range and corresponding incubation time periods. As expected 
there was observation of the direct correlation between incubation time and 
absorbance readings due to cell proliferation and hence, increased cell density at 
each subsequent checkpoint. Interestingly, at 10% v/v sera concentration 
absorbance readings (which is a direct indication of cell viability) start to reduce 
at all incubation time periods. This might indicate a beginning of cytotoxic nature 
of the extract towards HaCat cells. Hence, much higher incubation time frames of 
24 h was chosen to observe the effects of prolonged exposure to the extract on 
the HaCat cells. The low concentration parameters were kept constant, and in 
figure 4.2 no cytotoxicity was observed.  
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Figure 4.2: Effect of variable concentrations (0.1%, 0.5%, 1%, 2%, 5% and 10% 
v/v) of abalone sera on the viability of HaCat cells which were treated for 24 
hour and 48 hour. Absorbance detected at 450 nm.  
 
In contrast, a stark increase in cell proliferation is indicated at extract 
concentrations from 0.1 % to 5 % v/v, particularly at 48 h with 0.1% and 0.5 
% v/v abalone sera concentrations. This led to testing the cytotoxicity at 
higher concentrations of 10 %, 20 %, 40 %, 60 %, 80 % and 100 % for shorter 
incubation time frames of 30 min, 2 h, 4 h and 6 h. As depicted in figure 4.3 at 
this higher concentration range cytotoxicity is observed, however it is not 
significant and CC50 is not reached.  
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Figure 4.3: Effect of variable concentrations (10, 20, 40, 60, 80 and 100% v/v) of 
abalone sera on the viability of HaCat cells which were treated for 30 min, 2 
hour, 4 hour and 6 hour. Absorbance detected at 450 nm.  
 
Approximately there is a 30% decrease in cell viability for all incubation time 
frames. A maximum abalone sera concentration of 20% is thus chosen for 
subsequent cytokine assays for the results to be unaffected by the cytotoxicity 
of abalone sera. As expected there was again observation of the direct 
correlation between incubation time and absorbance readings due to cell 
proliferation and hence, increased cell density at each subsequent checkpoint. 
The number of cells per well for the cytotoxicity assay was reduced for the 
absorbance readings to fall below 1 and the experiment was repeated with the 
higher concentration range of 10 %, 20 %, 40 %, 60 %, 80 % and 100 % under 
diverse incubation time frames of 30 min, 1 h, 4 h, 24 h and 48 h. The results 
at figure 4.4 shows no observed cytotoxicity at 30 min, 1 h, 4 h and 24 h.  
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Figure 4.4: Effect of variable concentrations (10, 20, 40, 60, 80 and 100% v/v)  
of abalone sera on the viability of HaCat cells which were treated for 30 min, 1 
hour, 4 hour and 24 hour and 48 hour. Absorbance detected at 450 nm. 
However, at 48 h there was an anomalous 50% reduction of cell viability at 
10% v/v sera concentration, low concentration proving to be more cytotoxic 
than the higher concentrations. This may be due to the structure of the 
hemocyanin and coagulation or agglomeration properties.  This does not 
cause concern as for subsequent cytokine assays, incubation time of extract 
chosen was much shorter.  
The cytotoxic effect of variable concentrations of purified hemocyanin (as 
percentage of 400 microgram/mL solution) on the viability of HaCat cells 
which were treated for 30 min 24 h and 48 h were tested and no observed 
cytotoxicity surfaced (Figure 4.5) in the concentration range 1 %, 2 %, 4 %, 6 
%, 8 % and 10 % v/v. 
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Figure 4.5: Effect of variable concentrations of purified hemocyanin (1%, 2%, 
4%, 6%, 8%, 10% as percentages of 400 microgram/mL solution) on the 
viability of HaCat cells which were treated for 30 min 24 h and 48 h. Absorbance 
detected at 450 nm. 
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Furthermore, effect of variable concentrations (1 %, 2 %, 4 %, 6 %, 8 % and 10 
% as percentages of 400 microgram/mL) of abalone sera and purified AH  were 
tested on PC-3 cells, incubated for 24 h. Again, no observed cytotoxicity surfaced 
for this concentration range as depicted in Figure 4.6 
 
Figure 4.6: Effect of variable concentrations of abalone sera and purified abalone 
hemocyanin ((1%, 2%, 4%, 6%, 8%, 10% as percentages of 400 microgram/mL) 
on PC-3 cells, treated for 24 h. Absorbance detected at 450 nm. 
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Immunomodulatory 
Effects on HaCat Cells & 
Human Primary Oral 
Keratinocytes 
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5.1 Results 
 
Variable duration of treatment and concentration of test extracts were 
investigated to obtain an abalone hemolymph treatment model on human 
keratinocytes. BD Cytometric Bead Array (CBA) Human inflammatory assay was 
used to quantify the six cytokine concentrations (IL-1β, IL-12, IL -6, IL- 8, IL-10 
and TNF-alpha). Amongst these, the biggest impact was observed particularly on 
the concentrations of TNF-alpha, IL-6 and IL-8.  
 
5.1.2   Effect of short duration treatment with abalone hemolymph  
 
HaCat cells were treated with low concentrations of abalone hemolymph (2 % 
v/v and 5% v/v) with a short treatment time spanning from 15 min to 2.5 h. 
Short treatment time was investigated to observe the instantaneous cytokine 
modulation upon contact with low concentration abalone hemolymph. This 
would give an indication of the sensitivity and effectiveness of the treatment on 
these cell types.   
 
 
5.1.2.1 Immunogenic effects with 5% v/v abalone sera  
 
In the process of experimental design optimization, a study of immediate 
(15 min, 30 min and 45 min) immune response on HaCat cell triggered by 
treatment with 5% v/v abalone sera was conducted. A slight increase in the IL-8 
and IL-6 concentrations compared to the control was observed at 15 min and 30 
min incubation mark (figure 5.1 and figure 5.2) followed by a reduction in the 
same cytokines at 45 min mark (figure 5.3) This was, however, not a significant 
difference and further optimization of the experiment was required. 
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Figure 5.1: Immunogenic effects of 15 min treatment with 5% v/v abalone sera 
concentration on HaCat cells and determination of cytokine concentration (IL-6 
and IL-8).  (p<0.05) Data obtained with flow cytometry.   
 
 
 
 
 
 
Figure 5.2: Immunogenic effects of 30 min treatment with 5% v/v abalone sera 
concentration on HaCat cells and determination of cytokine concentration (IL-6 
and IL-8). (p<0.05) Data obtained with flow cytometry.   
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Figure 5.3: Immunogenic effects of 45 min treatment with 5% v/v abalone sera 
concentration on HaCat cells and determination of cytokine concentration (IL-6 
and IL-8). (p<0.05) Data obtained with flow cytometry.   
 
 
Immune response on HaCat cell triggered by treatment with 5% v/v abalone 
sera (15 min, 30 min and 45 min treatments) was conducted. A slight increase in 
the IL-8 and IL-6 concentrations compared to the control was observed at 15 
min and 30 min incubation mark followed by a reduction in the same cytokines 
at 45 min mark. This was, however, not a significant difference and further 
optimization of the experiment was required. 
 
 
5.1.2.2 Immunogenic effects with 2% abalone sera 
 
To increase the method’s sensitivity, a higher seeding cell density was 
required for more reliable results. With much higher cell seeding density and 
short treatment time of 30 min, 1.5 h and 2.5 h no significant immune response 
was observed in terms of IL-8 and IL-6 concentration changes as depicted in 
figure 5.4, figure 5.5 and figure 5.6, however, the increased cell seeding density 
corresponded to heightened cytokine levels which was the purpose of this 
experiment to optimize the experimental design in terms of sensitivity. It is 
worth noting that basal IL-8 concentration in HaCat cells is 7 fold greater than 
their basal IL-6 concentration. 
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Figure 5.4: Immunogenic effects of 30 min treatment with 2% v/v abalone sera 
concentration on HaCat cells and determination of cytokine concentration (IL-6 
and IL-8). (p<0.05) Data obtained with flow cytometry.   
 
 
 
Figure 5.5: Immunogenic effects of 1.5 h treatment with 2% v/v abalone sera 
concentration on HaCat cells and determination of cytokine concentration (IL-6 
and IL-8). (p<0.05) Data obtained with flow cytometry.   
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Figure 5.6: Immunogenic effects of 2.5 h treatment with 2% v/v abalone sera 
concentration on HaCat cells and determination of cytokine concentration (IL6 
and IL-8). (p<0.05) Data obtained with flow cytometry.   
 
 
 
Short treatment time of 30 min, 1.5 h and 2.5 h no significant immune response 
was observed in terms of IL-8 and IL-6 concentration changes as depicted. 
However, the increased cell seeding density corresponded to heightened 
cytokine levels, which was the purpose of this experiment to optimize the 
experimental design to produce higher yield of cytokines. It is worth noting that 
basal IL-8 concentration in HaCat cells is 7 fold greater than their basal IL-6 
concentration. 
 
 
 
5.1.3 Effect of extended treatment with abalone hemolymph and its 
components 
 
5.1.3.1 Immunogenic effects of 16 h treatment with variable 
concentrations of different extracts  
 
A study with longer incubation time period of 16 h with increased seeding cell 
density aimed at increased cytokine response was then conducted. Abalone sera 
was ultrafiltered according to the protocol outlined previously, and purified 
hemocyanin and the permeate were collected to be used as treatment extracts. 
More than 2 fold reduction in IL-6 concentration was observed on all tested 
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extracts (20% sera, 10% sera and 20% v/v permeate), while 1.5 fold reduction 
in IL-6 was observed with treatment with purified AH as shown in figure 5.7. The 
abalone sera permeate was the most potent extract with the most 
immunomodulating property amongst the three extracts tested.  
 
 
Figure 5.7: Immunogenic effects of 16 h treatment with 10% and 20% abalone 
sera, 20% purified AH and 20% v/v sera permeate concentrations on HaCat cells 
and determination of IL-6 concentration. (p<0.05) Data obtained with flow 
cytometry.   
 
IL-8 concentrations were also reduced by approximately 25 % compared to the 
control with treatment of 10% and 20% v/v abalone sera, while the permeate 
and purified AH were less effective in modulating IL-8 as shown in figure 5.8 
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Figure 5.8: Immunogenic effects of 16 h treatment with 10% and 20% v/v 
abalone sera, 20% purified AH and 20% sera permeate concentrations on HaCat 
cells and determination of IL-8 concentration. (p<0.05) Data obtained with flow 
cytometry 
 
 
There was a significant 9-fold increase in TNF-alpha concentrations in the cell 
supernatant particularly on treatment with 20%  v/v sera, while no significant 
modulation of this cytokine was observed upon treatment with purified 
hemocyanin and the permeate. This is demonstrated in figure 5.10. 
 
 
Figure 5.10: Immunogenic effects of 16 h treatment with 10% and 20% v/v 
abalone sera, 20% purified AH and 20% sera permeate concentrations on HaCat 
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cells and determination of TNF-alpha concentration. (p<0.05) Data obtained 
with flow cytometry. 
 
5.1.3.2       6 day dose dependent study on priming of HaCat cell  
 
 
The effect of a 6 day treatment with sera was tested to observe any priming 
effect on the cells that may modulate the cytokines differently. HaCat cells were 
supplemented with 10% and 20% v/v sera each day, and media changed after 
1.5 hours. Same was repeated each day for 6 consecutive days. This was done to 
mimic a daily dose model. According to the results in figure 5.10 compared to the 
control, different concentration of sera indicated different effects. 10% v/v sera 
concentration indicated a 22% inhibition in IL-6 after 6 days. While 20% v/v 
sera concentration indicated a stark 40% increase in IL-6 concentration after 6 
days. This indicates that on a dosage basis model, concentration of sera plays a 
crucial role in steering the immune response. 
 
 
 
 
Figure 5.10: Immunogenic effects of 6 day dosage treatment (1.5 h treatment per 
day) of HaCat cells with 10% and 20% v/v abalone sera and determination of IL-
6 concentration. (p<0.05) Data obtained with flow cytometry. 
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6 with 20% v/v sera, here the effects of 20% v/v sera concentration does not 
differ much from the control. This again stresses the importance of sera 
concentration on a dosage basis model. 
 
 
Figure 5.11: Immunogenic effects of 6 day dosage treatment (1.5 h treatment per 
day) of HaCat cells with 10% and 20% v/v abalone sera and determination of IL-
8 concentration. (p<0.05) Data obtained with flow cytometry. 
 
An additional stimulating effect on IL-1β was noted as shown in figure 5.12, 
which was solely attributed to the 6 day treatment as the effect on IL-1β was not 
previously observed on the 16 h incubation model.  
 
 
 
Figure 5.12: Immunogenic effects of 6 day dosage treatment (1.5 h treatment per 
day) of HaCat cells with 10% and 20% v/v abalone sera and determination of IL-
1β concentration. (p<0.05) Data obtained with flow cytometry. 
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TNF-alpha concentration was also modulated to result in a 12-fold increase 
compared to untreated control, during the 6 day treatment, specifically by 20% 
v/v sera concentration. Surprisingly, 10% v/v sera concentration did not have 
any such modulatory effect, which allows us to conclude that the sensitivity of 
HaCat cell of TNF-alpha production drastically increases between sera 
concentrations of 10% and 20%, reflecting almost an exponential increase, as 
shown in figure 5.13. 
 
 
 
 
 
Figure 5.13: Immunogenic effects of 6 day dosage treatment (1.5 h treatment per 
day) of HaCat cells with 10% and 20% v/v abalone sera and determination TNF-
alpha concentration. (p<0.05) Data obtained with flow cytometry. 
 
 
 
5.1.4 Dose and Time-dependent modulation of IL-6 and IL-8 
 
Another study was conducted for the quantification of IL-6 and IL-8 in HaCat cell 
supernatant post incubation with 1%, 5%, 10% and 20% v/v sera for 1 h, 2 h and 
5 h.  Result indicates (figure 5.14 and figure 5.15) the release of IL-6 and IL-8 
increase with higher treatment time. Dose dependent effect for the concentration 
range tested (1% to 20%) was not observed. 5 h treatment time clearly indicates 
a significantly higher IL-6 and IL-8 production compared to 1h, 2 h or the 
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control. As expected there was an increase of cytokine production with time. 
Including two other controls at different time points would have helped to see 
the effect of the treatments 
 
Figure 5.14: Quantification of IL-6 in HaCat cell supernatant post treatment with 
1%, 5%, 10% and 20% v/v sera for 1 h, 2 h and 5 h. Data obtained with Flow 
Cytometry. Indicating the release of IL-6 increases with higher treatment time. 
Dose dependent effect for the concentration range tested (1% to 20% v/v) is not 
observed. 5 h treatment time clearly indicates a significantly higher IL-6 
production compared to 1h, 2 h or the control (0%).  
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Figure 5.15: Quantification of IL-8 in HaCat cell supernatant post incubation with 
1%, 5%, 10% and 20% v/v sera for 1 h, 2 h and 5 h. Data obtained with Flow 
Cytometry. Indicating the release of IL-8 increases with higher treatment time. 
Dose dependent effect for the concentration range tested (1% to 20% v/v) is not 
observed. 5 h treatment time clearly indicates a significantly higher IL-8 
production compared to 1h, 2 h or the control (0%).  
 
 
Dose dependent effect for the concentration range tested (1% to 20% v/v) is not 
observed. 5 h treatment time clearly indicates a significantly higher IL-6 and IL-8 
production compared to 1h, 2 h or the control. As expected there was an increase 
of cytokine production with time. Including two other controls at different time 
points would have helped to see the effect of the treatments. 
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5.2  Immunomodulatory effects on Human Oral Primary Keratinocytes  
 
 
5.2.1 Results 
 
The abalone hemolymph ingestion study mentioned in Chapter 1 had shown 
modulation in cytokine concentration in the serum of patients treated with oral 
dosage of the whole hemolymph. The contact barrier between the extract and 
the recipient were oral keratinocytes. Immunomodulatory effect of the abalone 
hemolymph, and its components, on the human primary oral keratinocytes was, 
thus, crucial in our investigation. Determination of cytokine concentration 
modulation at this site was an important aspect in our research to validate our 
hypothesis.  
 
Maximum concentration of 20% v/v sera was used as a treatment for 16 h 
incubation with the Human Primary Oral Keratinocytes to test the effect on 
cytokine concentration.  
 
In summary, immunomodulatory properties of the three extracts at varying 
concentrations (dose-dependent) on Human Oral Primary Keratinocytes has 
been demonstrated. Permeate was found to be the most potent of all extracts in 
cytokine modulation for both the cytokines of interest.  
 
5.2.2 Immunogenic effects of 16 h treatment with 20% abalone sera 
concentration 
 
A sharp 35 fold increase in IL-8 concentration and 23 fold increase in IL-6 
concentration was observed as shown in figure 5.16. In terms of basal cytokine 
expressions of Human Oral Keratinocytes, concentrations of IL-8 are twice as 
much as IL-6 concentration. This can be visualized in figure 5.16 that shows the 
shifting means of IL-6 and IL-8 peaks as compared to the control.  
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Figure 5.16: Immunogenic effects of 16 h treatment with 20% v/v abalone sera 
concentration on Human Primary Oral Keratinocytes and determination of 
cytokine concentration (IL-6 and IL-8). (p<0.05) Data obtained with flow 
cytometry.   
 
 
 
 
5.2.3     Dose Dependent effect of abalone sera on Human Oral Primary 
Keratinocytes 
 
Confirming dose-dependent effect of abalone sera on human oral keratinocytes 
was important to demonstrate the immunomodulatory properties of the sera 
and it is, thus, validated as shown in figure 5.17. 5% v/v sera concentration 
yields 4 fold increase, 10% v/v sera concentration yields 6 fold increase and 
20% v/v sera concentration yields 10 fold increase in IL-6 concentration in 
Human Oral Keratinocytes cell supernatant after treatment.  
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Figure 5.17: Dose-dependent immunogenic effects of 16 h treatment with 5%, 
10%, 20% v/v abalone sera concentration on Human Primary Oral Keratinocytes 
and determination of IL-6 concentration. (p<0.05) Data obtained with flow 
cytometry.   
 
The effect on IL-8 concentration seemed to reach a plateau at approximately 8 
fold increase at 5%, 10% and 20% v/v sera concentration treatment of the 
Human Oral Keratinocytes as shown in figure 5.18. This suggests that the Human 
Oral Keratinocytes are much more sensitive to the sera in terms of IL-8 
modulation than IL-6 modulation. Further experiment with sera concentrations 
much lower than 5% v/v is required for dose-dependent effect to show. 
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Figure 5.18: Dose-dependent immunogenic effects of 16 h treatment with 5%, 
10%, 20% v/v abalone sera concentration on Human Primary Oral Keratinocytes 
and determination of IL-8 concentration. (p<0.05) Data obtained with flow 
cytometry.   
 
 
Figure 5.19 shows the dose-dependent effect of purified AH treatment on IL-6 
where 1300 microgram/ml yields a two fold increase and 2300 microgram/ml 
yields 2.5 fold increase in concentration. As with the sera, sensitivity of Human 
Oral Keratinocytes to purified AH in terms of IL-8 modulation is higher than IL-6 
modulation; as shown in figure 5.20, 1300 microgram/ml yields a 5 fold increase 
in IL-8 concentration after treatment and 2300 microgram/ml yields 8 fold 
increase in concentration after treatment. Hence, the dose dependent effect of 
purified AH was demonstrated. 
 
 
Figure 5.19: Dose-dependent immunogenic effects of 16 h treatment with 
variable concentrations of purified AH on Human Primary Oral Keratinocytes 
and determination of IL-6 concentration. (p<0.05) Data obtained with flow 
cytometry.   
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Figure 5.20: Dose-dependent immunogenic effects of 16 h treatment with 
variable concentrations of purified AH on Human Primary Oral Keratinocytes 
and determination of IL-8 concentration. (p<0.05) Data obtained with flow 
cytometry.   
 
5.2.4       Dose dependent effect of Abalone Sera Permeate 
 
Abalone sera permeate was tested as a treatment on the Human Oral 
Keratinocytes and the dose dependent effect was observed as shown in Figure 
5.21. The aim was to obtain high, medium and low concentration of the 
permeate. These were obtained by dilution, and it was out of our control to 
obtain exact or rounded concentrations. These concentrations of 63 and 398 
microgram/ml were measured using Qubit after dilution. The difference 
between them was large enough for a valid dose-dependent study. 
63 microgram/ml permeate yielded a 2.4 fold increase in IL-6 concentrations, 
followed by 3.5 fold increase with 398 microgram/ml and 4.5 fold increase with 
556 microgram/ml of sera permeate. Again, sensitivity of Human Oral 
Keratinocytes to abalone sera permeate (similar to the sera and purified AH) in 
terms of IL-8 modulation is higher than IL-6 modulation; as shown in figure 5.22, 
63 microgram/ml yields a 6 fold increase in IL-8 concentration after treatment, 
398 microgram/ml yields an anomalous 13 fold increase and 556 microgram/ml 
yields an 8 fold increase in IL-8 concentration after treatment.  
The drastic increase may be due to a large pipetting error in either cell seeding 
or treatment dose. The “decrease” in 556 microgram/ml treatment is still higher 
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than the yield obtained from 63 microgram/ml. Hence, it makes sense to call the 
drastic increase an anomaly/experimental error. 
Hence, the dose dependent effects of sera permeate was demonstrated. 
 
 
Figure 5.21: Dose-dependent immunogenic effects of 16 h treatment with 
variable concentrations of abalone sera permeate on Human Primary Oral 
Keratinocytes and determination of IL-6 concentration. (p<0.05) Data obtained 
with flow cytometry.   
 
 
Figure 5.22: Dose-dependent immunogenic effects of 16 h treatment with 
variable concentrations of abalone sera permeate on Human Primary Oral 
Keratinocytes and determination of IL-8 concentration. (p<0.05) Data obtained 
with flow cytometry.   
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CHAPTER 6:  
 
Immunomodulatory 
Effects On Prostate 
Cancer Cells & 
Identification Of The 
Permeate Proteins 
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6.0 Introduction  
 
The role of hemocyanin as an immunotherapeutic for various forms of cancer 
has been studied extensively with some promising results. The most prevalent 
KLH and now CCH (Concholepas concholepas hemocyanin), has been widely used 
as alternatives in superficial bladder cancer (SBC) immunotherapy. 
Hemocyanins are particularly preferable as a treatment for superficial urinary 
bladder cancer (SBC), which is most commonly treated with Bacillus Calmette-
Guerin (BCG). Unlike BCG that has the risk of anaphylactic reaction or formation 
of large abscess, the fact that hemocyanin does not cause side effects, renders 
them preferable for long-term repetitive treatments (Campo et. al, 2011). Thus, 
the search for natural immunostimulants is a promising avenue to explore 
(Lamm et. al, 2003). Olsson et al treated superficial bladder cancer 
with immunization of patients with 5 mg of KLH and observed a significant 
reduction in the recurrence of superficial bladder cancer. Reduction in tumor 
growth in mice was reported by Lamm et al . KLH has also shown bladder tumor 
recurrence prevention with negligible side effects (Winkner et. al, 2000;Jurincic 
et. a,l 1996) .   
 
Due to the similarity between the structures of KLH and AH, the effect of AH on 
treating cancer cells is expected to be in line with the effects of KLH and thus, we 
treated prostate cancer cell line (PC-3) with purified AH, sera and sera permeate 
we expected immunomodulatory effects as well as cell proliferation inhibition. 
Effects of KLH on prostate cancer cell lines have been studied mainly as carrier 
protein, including 10 clinical trials in various stages of development mainly using 
MUC-2 antigen with KLH. Monovalent and poly-valent vaccines are under debate  
since, although, both have immunostimulatory effects on prostate cancer, 
monovalent vaccines yield higher titres of antibodies while poly-valent vaccines 
reach a greater range of antibodies (Slovin et. al, 2007). A more recent study 
conducted on prostate cancer patients, with the use of an adjuvant of another 
form of hemocyanin, CCH, showed that it is safe and is able to generate memory 
T cell responses in patients and is thus a potential substitute for KLH in 
immunotherapies.  
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The effect of KLH (50 μg/well), IL-2 (10,000 IU/well) , IFN-a (1500 IU/well) and 
their combination has demonstrated an astounding reduction of HTB68 
melanoma cell line where KLH and IFN-a combined yielded a 67% reduction in 
cell growth and increased apoptotic activity by 14% (McFadden et. al, 2006). 
KLH has thus shown to enhance the effect of IFN-a, which is a powerful 
immunotherapeutic against melanoma (Rizvi et. al., 2007). Cancer cell lines 
estrogen-dependent breast (MCF-7), estrogen-independent breast (ZR75-1), and 
pancreas (PANC-1, MIA-PaCa) were treated with KLH and significant inhibitions 
of cell growth was observed, while a 6% inhibition of prostate cancer cell growth 
was also observed upon treatment with KLH (Riggs et. al, 2002).  
 
Other forms of cancer such as epithelial derived Barrett's esophageal 
adenocarcinoma in an in vitro model was tested by McFadden et. al, (2003) 
where a reduced viability of cancer cells in a dose and time-dependent manner 
were observed upon treatment with KLH. Several other in vivo and in vitro 
hemocyanin treatment models exist for various forms of cancer such as breast, 
oesophageal, melanoma, pancreatic and prostatic.  
 
 
6.1 Results 
 
 
In summary, immunomodulating properties of the three extracts at varying 
concentrations on PC-3 cell have been demonstrated. Permeate continues to be 
the extract with strongest immunomodulating potency on IL-6. A cell 
morphology change and reduction in cell size on prostate cancer cells is 
observed when treated with the permeate.  
 
6.2    Immunogenic effects of variable extracts with 5 h treatment 
 
Prostate cancer cell line, PC-3 cells, were treated with variable concentrations of 
the abalone sera for 5 h and the resulting cytokine concentration changes were 
determined. Figure 6.1 shows that all three extracts (sera, AH and permeate) 
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have a modulatory effect inhibiting production of IL-6 in the PC-3 cells. 
Permeate, again, is proven to be the most potent treatment extract, inhibiting IL-
6 in PC-3 cells by over 50%, followed closely by 20% v/v sera. Purified AH, 
although has the inhibiting IL-6 production effect, is the least potent among the 
three, inhibiting the IL-6 concentration by 27%. 
 
 
 
 
 
Figure 6.1: Immunogenic effects of 5 h treatment with 20% v/v abalone sera, 
20% purified AH and 20% sera permeate concentrations on PC-3 cells and 
determination of IL-6 concentration. (p<0.05) Data obtained with flow 
cytometry. 
 
 
A 29% reduction in IL-8 results from treatment with permeate for 5 h, followed 
by a 25% reduction from treatment with AH, and lastly a 16% reduction from 
treatment with the abalone sera. This is portrayed in Figure 6.2. Basal IL-8 
concentration is much more abundant in PC-3 cells than IL-6 as can be seen in 
Figure 6.2. 
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Figure 6.2: Immunogenic effects of 5 h treatment with 20% v/v abalone sera, 
20% purified AH and 20% sera permeate concentrations on PC-3 cells and 
determination of IL-8 concentration. (p<0.05) Data obtained with flow 
cytometry 
 
 
The most potent treatment extract is the permeate, inhibiting IL-6 in PC-3 cells 
by over 50%, followed closely by 20% v/v sera. Purified AH, although has the 
inhibiting IL-6 production effect, is the least potent among the three, lowering 
the IL-6 concentration by 27%. 29% reduction in IL-8 results from treatment 
with permeate for 5 h, followed by a 25% reduction from treatment with AH, and 
lastly a 16% reduction from treatment with the abalone sera.  
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6.3    Effect of extracts on Cell morphology 
 
The effect of abalone sera, AH and permeate 5 h incubation on the prostate 
cancer cell morphology was observed and findings in Figure 6.3 suggest that the 
permeate had a direct effect on cancer cell morphology resulting in size and 
aspect reduction of the cells compared to untreated control. No such effect was 
observed with abalone sera and AH treatment. This may be a crucial finding to 
support the permeate’s capacity in reducing the size and aspect of cancer cells on 
direct contact.  
 
 
 
   (A)                                                                              (B)                      
 
 
  
 
 
 
 
 
 
 
 
(C)                                                                                  (D)    
 
 
Figure 6.3: Effect of abalone sera, purified AH and permeate 5 h treatment on 
the morphology of PC-3 cells. The PC-3 cells are at 100 x magnification. (A) 
Control  (B) 20% v/v sera (C) 20% v/v hemocyanin     (D) 20% v/v permeate.                                                     
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6.4 Identification of the permeate proteins using Western Blot 
Due to the continued high potency of the hemolymph permeate in 
immunomodulation across all tested cell lines, it was important to have an 
insight on the nature and origin of the permeate proteins. To detect if the 
permeate proteins originate from the hemocyanin (dissociated fragments) or if 
they are entirely unrelated to the hemocyanin, Western Blot was performed. 
Three different concentrations of permeate samples were tested. Due to the low 
concentration of even the undiluted permeate, Coomassie blue stain could not 
detect the permeate proteins. However, the highly sensitive Western Blot 
experiment showed protein bands at at least 11 molecular weight markers as 
shown in Fig 6.4. All of which are detected by anti hemocyanin antibody. This 
suggests that these small proteins are fragments/sub-units/functional units of 
the hemocyanin dissociated from it. Clearly, the 1st permeate, which is undiluted, 
shows the strongest stain, followed by the 2nd and 3rd permeate. Concentrations 
of these permeates are shown in Table 6.1. 
 
Figure 6.4:  Identify the protein in the permeates by Coomassie blue stain (A) 
and western blot with the anti-hemocyanin antibody (B). Marker units: kDa. 
Samples were processed by me, while the Coomassie Blue Stain and Western 
Blot experiment was performed by Jiadai Wu at Westmead Millenium Institute.  
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Protein cannot be detected by Coomassie blue stain due to the little amount 
(Figure 6.4-A). Same amount of sample was loaded for Western blot with the 
polyclonal antibody raised against native hemocyanin.  
 
 
Table 6.1 Total protein concentrations of three permeates 
 
Absorbance Concentration (mg/ml) 
1st permeate 0.195 0.13 
2nd permeate 0.056 0.037 
3rd permeate 0.026 0.017 
 
 
The result indicated protein bands at at least 9 molecular weight markers 
ranging from 28 kDa to 250 kDa (and a faint band above the 250 kDa marker) in 
the 1st permeate. A very dense protein band was identified at 55 kDa marker for 
this sample.  
 
The 2nd permeate consisted of the highest number of protein bands (at 11 
molecular weight markers, 9 of them at identical molecular weight to 1st 
permeate). The additional bands were identified between 100 kDa and 250 kDa.  
 
The 3rd permeate, being the most diluted amongst the three samples, showed a 
series of faint protein bands at identical molecular weight markers as 2nd 
permeate from 55 kDa to 250 kDa.  
 
The protein bands detected are the proteolytic molecules derived from native 
hemocyanin (Figure 6.4-B). 
 
Permeate with the highest concentration of proteins showed the most significant 
modulation of IL-6. In contrast, permeate with medium concentration of proteins 
showed the most significant modulation of IL-8. The modulation of IL-8 may be 
caused by the additional proteins detected exclusively in the 2nd permeate (Fig. 
5.21 and Fig. 5.22).  
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7.0 Discussions 
 
Immunomodulatory properties of Haliotis rubra (abalone) hemocyanin (AH) 
along with whole sera and sera permeate, had been investigated on three 
different cell types, two of which are human keratinocytes and one of which is a 
human prostate cancer cell line. Immunomodulatory and dose-dependent effects 
on all three cell types through the modulation of cytokines is observed for all 
three extracts, while the sera permeate (consisting of hemocyanin derived 
proteins, according to Western Blot Analysis) consistently proved to be the most 
potent immunomodulator in all cases. Among the tested six cytokines (IL-10, IL-
8, IL- 6, IL-12, TNF-alpha and IL-1β), significant modulation of IL-6 and IL-8 is 
observed on all cell types and extracts used. Modulation of IL-1β and TNF-alpha 
were also observed under certain parameters, such as daily dose model on HaCat 
cells.  
 
The significance of this finding branches out to and opens a vast field of potential 
anti-viral, anti-bacterial and anti-cancerous effects of this marine-derived 
extract. Some immunomodulatory behavior of certain hemocyanins have been 
previously reported; studies by Zhong et.al (2016) have found the ability of three 
different hemocyanins (Concholepas concholepas, Fissurella latimarginata, and 
Megathura crenulata (keyhole limpet)) to induce a potent Th1 dominant immune 
response following upregulation of IL-6, TNF-alpha and IL-1β in macrophages, 
which is coherent with the findings in this study. Downregulation effects of these 
hemocyanins were also observed by Zhong et. al on different cytokine gene 
expressions including IL-4 and IL-5. Additionally, Donnarumma et. al (2010) 
found an increase in IL-1β, IL-6, IL-8, TNF-alpha, in epithelial cells upon 
treatment with KLH, all of which fall common with our results with Human 
Primary Oral Keratinocytes (a form of epithelial cells). Findings of Zhong et. al 
(2016) and Donnarumma et. al (2010) and the ability of hemocyanin to 
upregulate and downregulate certain cytokines is, thus, in accordance with our 
findings. The in vitro production of cytokines by mucosal lymphocytes 
immunized by oral administration of KLH that used cholera toxin as an adjuvant 
showed heightened levels of IL-4, IL5 and IL-6 with lower levels of IL-2 and 
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interferon-gamma (IFN-gamma) in the lamina propria (mucosa). This finding is 
in line with our research outcome of human oral keratinocytes with significant 
increase in IL-6 levels. However, HaCat cells were not a suitable model for the 
primary keratinocytes as they responded differently to treatment (a response 
similar to PC-3 cells) due to their immortalized status, and hence its effect on 
their receptors and various signaling pathways. 
 
The effect of immunomodulation with whole sera and permeate has not been 
studied previously. While there are fragments of the hemocyanin present in the 
sera permeate, it is not clear if any non-hemocyanin derived proteins are present 
in the permeate that facilitates the augmented immunomodulatory effect of the 
permeate compared to purified hemocyanin and whole sera. Zanjani et. al (2014) 
found 20kDa size proteins in the permeate, which along with other fragmented 
proteins, are derived from hemocyanin according to our analysis.  
 
An interplay between the innate and humoral immune response is observed in a 
number of cases. Immunogenicity of Rapana thomasiana hemocyanin (RTH) has 
been found by Tichorbanov et. al (2008), where humoral immune response is 
observed in vivo through secretions of anti-hemocyanin antibodies against RTH, 
two sub units of the hemocyanin RTH1 and RHT2 upon immunization with the 
extracts. Similar humoral immune response has been found with KLH as a 
carrier with saponin adjuvant, where high titres of IgM and IgG were induced 
(Slovin et.al 2005). In addition, humoral response of heightened IgA levels were 
observed in the mucosa. It was thus assumed that reaction to cholera 
toxin/keyhole limpet hemocyanin is due to by Th2-type cytokines (Wilson et. al, 
1991). 
 
As the immunomodulatory effects of hemocyanin is evident on both innate and 
humoral immune response, it is important to decode the mechanisms that are 
involved in the process. There are quite a few hypothesis: while the mechanism 
of action initiated by macropinocytosis and clathrin-mediated endocytosis is 
reported by Arancibia et. al in the case of macrophage activation following 
hemocyanin inoculation, the mechanism of action on the keratinocyte level is yet 
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to be studied. The mechanism of action of Litopenaeus vannamei hemocyanin on 
human cervical cancer cells (Zheng et. al) follows apoptosis through 
mitochondria triggered pathway. This particular mechanism sheds light into a 
potential interaction of the hemocyanin and hemocyanin derived proteins with 
mitochondria to modulate the cytokines through receptors on the keratinocytes 
and cancer cell line in our study.  
 
Another possible mechanism could involve enhanced humoral immune response 
due to the association of modified fecal Lactobacillus content (Murai et. al 2016).   
This can be related to the study conducted by Murai et. al, 2016, where orally 
administered chickens (with KLH) have shown enhanced humoral immune 
response due to the above modification. This may be a mechanism of action in 
humans orally administered with AH followed by the modulation of IL-6 and IL-
8, bridging the innate immune response with humoral immune response in 
combating diseases such as HSV-1 and cancer.  
 
Alternatively, activation of NF-κB is a potential mechanism of immune response 
of the hemocyanin and hemocyanin derived proteins, as proven by Yasuda et. al 
(2016) in their study with KLH where human monocytic THP-1 cells 
demonstrated activation of NF-κB  through partial mediation by Syk and Erk 
pathways. The transcription factor, NF-κB, plays crucial roles in the immune 
system (Ghosh et al., 1998; Karin et. al, 2004) and the NF-κB activation results in 
the production of pro-inflammatory cytokines (Kingeter and Lin, 2012). The 
similarity between the structures of AH and KLH (constituting of high levels of 
sugar residues, unpublished data) supports the notion that this NF-κB activation 
may also be induced by AH as it is initiated through mannose or C-lectin 
receptors since, like KLH (Mansour et al. 2006), AH and AH derived proteins may 
also be rich in mannose. Additionally, Ines et. al (2013) reported that secretion of 
cytokines was dependent on the presence of oligosaccharides on FLH, which 
demonstrated a role of lectin/mannose receptors in the mechanism of 
hemocyanin action.  
There are observations that oppose this hypothesis; Endocytosis inhibition 
experiments performed on human DCs with an anti-mannose receptor antibody 
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and KLH, demonstrated the partial inhibition of KLH incorporation by DCs. 
Additionally, it continued the promotion of activation and maturation of DCs 
reflected by the up regulation of MHC class II molecules (Presicce et al., 2008).  
However, murine DCs pulsed with KLH did not undergo DC maturation (Teitz-
Tennenbaum et. al, 2008) coherent with the in vivo results (Teitz-Tennenbaum 
et al., 2008; Moltedo et al., 2009).  
 
The mechanism of action by the hemocyanin is also shown to involve the 
adaptive arm of immune response. As carbohydrates are natural adjuvant 
themselves, triggering the adaptive arm of immunity without any other adjuvant 
is quite possible by hemocyanins. A mechanism of CD4+ T cell reacting to 
preserved xenogenic peptidic sequences stimulate the T cells to secrete Th1 
cytokines. This results in a breakage of tumor tolerance and enhancement of 
immune response against the tumor. Arancibia et al. (2012) have found evidence 
that supports this mechanism of action, showing that high secretions of IFN-Y 
and IL-2, was found in lymph nodes after exposure to hemocyanin. Additionally, 
cytokine environment tending towards a Th1 response was observed when mice 
primed with CCH or KLH were exposed to bladder cancer cells. Furthermore, 
there was a significant increase of CD4+ T cells in the submucosa and urothelial 
cells, as opposed to only a slight increase in CD8+ T cells after intravesical KLH 
therapy in patients with bladder cancer (Jurincic et al. 1995). Lastly, tumor 
antibodies (IgG1 and IgG3 isotypes) resulted from KLH conjugated vaccines 
against cancer (Musselli et al, 2001).  
 
Hemocyanin has been studied extensively for cancer treatment. Research on the 
effect of KLH on bladder cancer has led to multicenter clinical trials confirming 
the efficacy of intravesically treated KLH on patients during varying stages of 
bladder cancer (Lamm et. al, 2000). However, it is worth noting that at the phase 
III clinical trial stage, when the anti-cancerous effects of KLH treatment on non-
muscle invasive bladder cancer was tested and compared to the effects of 
mitomycin (Lammers et. al, 2012), experiences of fever, flu-like symptoms, and 
fatigue occurred significantly more after KLH treatment but KLH tended to be 
more effective than mitomycin in preventing progression of cancer. Becker et. al 
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(2009) and Moltedo et. al (2006) have studied the effect of CCH on bladder 
cancer finding a reduction in tumor growth and prolonged survival. A further 
study conducted by Becker et. al subsequently identified the more potent 
subunit CCH-A that has greater anti tumor effect compared to CCH-B. This shows 
anti-tumor, and hence immunomodulatory, activity may vary between subunits 
of hemocyanin and it is, thus, worth studying different subunits of AH. 
 
The direct effect of IL-8 on prostate cancer cells have been reported by Waugh et. 
al (2008) where it is shown that IL-8 signaling increases proliferation and 
survival  prostate cancer cells, and potentiates the migration of cancer cells. He 
suggests that inhibiting the effects of IL-8 signaling may be a significant 
therapeutic intervention in targeting the tumor microenvironment. Additionally, 
Neveu et. al (2014) reported a direct correlation between IL-8 secretion and 
primary prostate cancer cell aggressiveness.  The suppression of IL-8 secretion, 
post treatment with the abalone hemolymph, is thus an indication of anti-
cancerous effect through immunomodulation.   
 
On the other hand, the role of IL-6 in prostate cancer is discussed by Nguyen et. 
al (2014) stating that IL-6 is able to promote prostate cancer cell proliferation 
and inhibit apoptosis in vitro and in vivo. IL-6 is also associated with aggressive 
prostate cancer phenotype. Lou et. al (2000) found that IL-6 induces prostate 
cancer cell growth by activation of stat3 signaling pathway. However, 
Mallinowska et. al (2009) reported the activation of androgen receptor in 
prostate cancer cell by IL-6. Either way, inhibition of IL-6 secretion have an anti-
tumor effect due to these reasons, which supports the finding of IL-6 suppression 
by abalone hemolymph treatment.  
 
Immune response is intricately involved in herpes simplex virus 1 (HSV 1), and 
in particular innate immune response plays a critical role in early control of the 
disease (Paludan et. al 2011). Human and animal herpes virus models have 
demonstrated signaling occurring number of TLRs including TLR2, which 
recognizes virion components including surface glycoproteins (Boehme et. al 
2006; Compton et. al 2003), which pinpoints dsRNA (Iwakiri et. al 2009) as well 
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as TLR9 which is responsible for the detection of genomic DNA (Lund et. al 
2003). As already found (Zanjani et. al 2014), abalone hemocyanin and derived 
proteins are glycoproteins that prevent viral entry by binding to viral 
glycoproteins, and thus, according to the above it may act on the immune system 
through the TLR signaling pathway. 
 
Nason et. al. (2016) found a significant association between Herpes Simplex 
Virus shedding and high levels of IL-6. The increase in IL-6 in primary oral 
keratinocytes may induce shedding of HSV-1, and according to Nason et. al 
(2016) the increased IL-6 may also prevent subsequent reactivation of the virus 
as long as the immune-environment remained optimal for this cause. 
Interestingly, Donnarumma et. al (2010) found an increase in IL-lβ, IL-6, IL-8, 
TNF-alpha, (i.e proinflammatory cytokines) in epithelial cells and concluded that 
their method of HSV-1 treatment indeed facilitates and triggers the 
proinflammatory immune response in HSV-1 infection. Additionally, the 
importance of targeted immune responses in different stages of the infection is 
also stressed. This corroborates the idea that abalone sera, purified AH and 
permeate can, indeed, be potential extracts that combat HSV-1 through 
immunomodulation, since there was observed augmentation in the levels of all of 
the above cytokines (IL-l B, IL-6, IL-8, TNF-alpha).  
 
Augmented levels of proinflammatory cytokines in the human primary oral 
keratinocyte cell supernatant, post treatment with abalone hemolymph extracts, 
fits well with reports of Tumpey et. al (1996) that shows both 
immunocompetent and immunodeficient mice, neutrophils play a significant role 
in controlling the replication and spread of HSV-1.  Milligan et. al (1999) 
suggested that neutrophils helped control HSV-2 in murine model of the 
infection. Both IL-6 and IL-8, the target cytokines modulated by the abalone 
hemolymph extracts, attract and activate neutrophils during infection and 
inflammation (Borish et. al, 1989; Hammond et. al, 1995). Hence, the IL-6 and IL-
8 modulatory effects of abalone hemolymph may have a direct effect on the 
attraction and activation of neutrophils in HSV infections.  
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The finding of permeate proving to be the most potent immunomodulator can be 
explained by the finding of Zhang et. Al (2004), which demonstrated that 
individual proteins were slightly more active than native hemocyanin. 
Additionally, the mixture proteins were much more active than native 
hemocyanin. This may correspond to the relative abundance of Haliotis rubra 
hemocyanin fragmented proteins in the permeate as compared to purified 
hemocyanin, and the higher immunomodulatory effect corresponding to the 
higher anti viral activity. It is also highly likely that the functional units of the 
hemocyanin fragmented in the permeate are responsible for the boosted 
immunomodulatory properties as compared to the whole sera or purified 
hemocyanin, however there is a lack of literature that studied this aspect. 
According to our findings, all 11 differently sized proteins present in the 
permeate are derived from hemocyanin. However, it may be possible that there 
are proteins present in the permeate, which were not detected in SDS-PAGE, that 
are foreign to hemocyanin.  
Nevertheless, an explanation may be found in the findings of Dang et al. (2011) 
that proposed antiviral activity of hemolymph from Haliotis laevigata, a closely 
related species to Haliotis rubra, was due to heat-resistant peptides and not 
hemocyanin. 
 
 
7.1 Conclusion 
 
Only a few immunomodulatory drugs are on the market today. Examples of these 
drugs include prostaglandins, cyclosporine A, levamisole, niridazole and 
penicillamine. As most of these have severe side effects new drugs from natural 
sources may offer new mechanisms of activity and may underpin new 
therapeutic approaches. 
 
The impact of naturally derived immunomodulators are potentially greater due 
to the preferable observation that there is minimal side effects associated with 
these compounds, in contrast to the synthetic immunomodulators commercially 
available in the market today (Natanranjan et. al 2016).  
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Immunomodulatory compounds particularly derived from shellfish have been 
widely studied in recent years, and proteins, peptides, lipopolysaccharides, 
glycoproteins and lipid derivatives are found to have the most 
immunomodulatory effects (Tzianabos et. al 2000). Proteinaceous molecules 
with much lower molecular weights have also demonstrated potent 
immunomodulation e.g lectins, glycoproteins, agglutinins, etc. 
 
The need for immunomodulatory drugs derived from natural sources is of great 
importance, as it minimizes the problems associated with cost and severe side 
effects in patients with viral diseases and cancer, both of which are intricately 
dictated by the state and responses of the immune system. 
  
The research questions in this case were:  
 Whether abalone sera, hemocyanin or the permeate have 
immunomodulatory properties.  
 What is the nature and degree of immunomodulation observed? 
 Which component of the sera is a more potent immunomodulator and 
what is the nature of the immunomodulatory extract?  
 What kind of immune response is triggered by the extract? 
 Is there any cytotoxicity to the host cells? 
 Is there an effect on the cancer cells? 
 
Answering these research questions would facilitate studies of hemocyanin as a 
cancer therapeutic and and as a model for developing new class of drugs for 
against diseases such as HSV-1. 
 
In this study, I demonstrated that Haliotis rubra sera, purified hemocyanin and 
permeate from the same, have no significant cytotoxicity to the host cells and yet, 
have a direct and powerful effect on the innate immune response by stimulating 
expression of inflammatory cytokines.  
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Immunomodulatory effect of abalone sera and its components has been 
demonstrated for the first time in in vitro system consisting of human oral 
primary keratinocytes. IL-6 and IL-8 were the target cytokines in all tested cell 
lines that responded to stimulation with abalone sera and its components.  
 
There was a sharp 35-fold increase in IL-8 concentration and 23 fold increase in 
IL-6 concentration with treatment of 20% v/v abalone sera, as compared to the 
untreated control. Further, dose-dependent effects of all extracts (whole sera, 
purified hemocyanin and permeate) were subsequently confirmed on the 
primary oral keratinocytes. It has also been shown that human oral 
keratinocytes are much more sensitive to the sera in terms of IL-8 modulation 
than IL-6 modulation. Additionally it has been demonstrated that the basal 
expression of IL-8 concentration in Human Oral Keratinocyte supernatant is 
twice as much as IL-6 concentration.  
 
Receptor saturation and agonistic affect was demonstrated at high 
concentrations of the sera and components. Long term stimulation is necessary 
to achieve sustained modulation of IL-6 and IL-8 necessitating the development 
of sustained release system for mucosal delivery. Although IL-10 was decreased 
in patients who consumed abalone sera previously (25 ml oral dose daily), no 
such reduction was demonstrated by cultured primary keratinocytes. This 
suggests that other cells beside keratinocytes were the potential targets for the 
components of abalone sera. 
 
The two cytokines are relevant for treatment of HSV and other viral infections 
and demonstrate potential for subsequent modulation of the innate immune 
system and engagement of the cellular immune system 
 
Treatment of HaCat cells with the abalone sera showed a 50% inhibition in IL-6 
expression, 21% inhibition in IL-8 expression and an increase in TNF-alpha 
concentration in the HaCat cell supernatant after 16 h treatment..  Other cytokine 
levels were unaltered.  
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A 50% inhibition of IL-6 expression and 29% inhibition of IL-8 expression was 
observed in prostate cancer cell line treated with abalone hemolymph permeate. 
Other extracts from the abalone hemolymph showed similar results. Abalone 
hemolymph also showed selectivity towards the cancer cells as their morphology 
was affected by the extracts, while the morphology of keratinocytes were not.  
Hence, it has been successfully demonstrated that all three extracts are capable 
of varying degrees of immunomodulation, targeting IL-6 and IL-8. Under some 
specific parameters mentioned above, effects on TNF-alpha and IL-1β (Other 
proinflammatory cytokines) have also been significant.  
 
Small proteins and peptides from the low molecular weight fraction of abalone 
sera (hemolymph permeate) have demonstrated higher immunomodulatory 
activity than native hemocyanin. The nature of the hemolymph permeate was 
studied to answer whether the proteins present in the permeate originate from 
hemocyanin or they are foreign to hemocyanin. Western Blot results showed 
that the proteins in the permeate are indeed fragments of the hemocyanin, which 
are more effective than the much larger parent molecule. This finding promises, 
upon isolation of the most immunomodulatory peptide fragmented in the 
permeate, that a synthetic hemocyanin fragment derived immunomodulatory 
drug in a form of peptide will be much simpler to formulate and produce on large 
scale and formulate. 
Overall, these results are very promising as they demonstrate the 
immunomodulatory potential of abalone hemolymph extract on three different 
cell lines. The results justify further studies on the immunological activity of 
these peptides and identifying the precise mechanism of action. 
 
7.2 Future Directions 
 
Functional studies are needed to demonstrate modulation of the immune system 
beyond cytokine release. Innate immune response modulation resulting from the 
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treatment with abalone sera, purified AH and the permeate should be further 
explored with studies involving cells of the innate immunity such as 
macrophages, T cells, NK cells and antigen presenting cells such as dendritic 
cells. Cytokine modulation in these cells as well as effects on their maturation 
should be studied. This will help mapping the , effector cells involved and 
identify the  receptors responsible for the triggered immune response. Signaling 
pathways and precise mechanism of action may be decoded. 
 
Modulation of the cellular immune response, and potential interplay between 
innate and adaptive immune system should also be investigated. 
 
Furthermore, studies should be extended to observe immunomodulatory effects 
of the abalone hemolymph on other human epithelial cells, such as fibroblasts. 
Screening of other cancer cells is also justified to understand the mechanism of 
hemolymph extracts’ direct anti-cancer effect. The promising observations 
presented in this work justify further, more detailed studies in this field. 
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Appendix 
 
 
A.1 Effect of Abalone Hemolymph  Treatment on IL-6 and IL-8  
 
Below are the effects of 20% v/v abalone hemolymph treatment observed on 
FACSCanto II scatter plots. The peaks shifting to the right post-treatment are that 
of IL-6 and IL-8. 
 
 Control 
 20% Sera 
 
Figure 8.1: FACSCanto II images of effects of 16 h 20% v/v sera treatment on the 
peaks of IL-6 and IL-8. 
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A.2 Effects of Abalone hemolymph extracts  
 
The modulation of IL-6 and IL-8 can be visualized in the scatter plots below 
(from FACSCanto II flow cytometer). Different extracts have variable degrees of 
immunomodulation as can be observed by the shifting peaks of IL-6 and IL-8. 
Control  
 (A)                                                                             (B) 
 
                
 
(C)                                      (D) 
  
Figure 8.2 : FACSCanto II images of effects of 16 h treatment of Human Primary 
Oral Keratinocytes with (A) Tris control, (B) 20% v/v Sera, (C) low concentration 
permeate and (D) high concentration purified AH on the peaks of IL-6 and IL-8. 
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A.3 Flow Cytometer Analysis Gating Strategy 
 
The gating strategy followed for the analysis of flow cytometric observations are 
demonstrated below. The beads enclosed by the gate are stained beads 
containing captured cytokines. The rest are cellular debris, which were not 
included in the analysis. This gating strategy was followed for observations 
under all experimental parameters.  
 
  
Figure 8.31: Flow cytometer Gating strategy for the analysis of cytokine 
concentration results observed.  
These beads were further sub-divided into 6 peaks of the 6 cytokines detected. 
Three (in some cases two) sub-populations: P2 , P3 and P4 were further gated as 
they showed the most modulation from the basal cytokine concentration. They 
are IL-8, IL-1β and IL-6 respectively. 
 
Figure 8.32: Gating of IL-6, IL-8 and IL-1β. 
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The figure below indicates the quantification of the detected cytokines in each 
gate P2, P3 and P4. Relatively, it can be concluded that IL-6 (P2) has experienced 
the highest immunomodulation followed by IL-6 and IL-1β. The cytokine 
concentration was quantified in pg/ml using FCAPArray software.  
 
Figure 8.33: Mean values of cytokines detected in each gated sub-population. 
 
 
 
 
 
 
 
 
 
 
